BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bode B, Garrett V, Messler J, McFarland R, Crowe J, Booth R, Klonoff DC. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. J Diabetes Sci Technol. 2020;14:813-821. [PMID: 32389027 DOI: 10.1177/1932296820924469] [Cited by in Crossref: 374] [Cited by in F6Publishing: 409] [Article Influence: 124.7] [Reference Citation Analysis]
Number Citing Articles
1 Nørgård BM, Zegers FD, Juhl CB, Kjeldsen J, Nielsen J. Diabetes mellitus and the risk of post-acute COVID-19 hospitalizations-a nationwide cohort study. Diabet Med 2023;40:e14986. [PMID: 36271495 DOI: 10.1111/dme.14986] [Reference Citation Analysis]
2 Tülüce D, Dikici İC, Kaplan Serin E. The effect of education of patients with type 2 diabetes at risk of covid-19 on symptoms and some metabolic outcomes: A randomized controlled study. Prim Care Diabetes 2023;17:3-11. [PMID: 36509658 DOI: 10.1016/j.pcd.2022.12.001] [Reference Citation Analysis]
3 Duarsa GWK, Sugianto R, Yusari IGAAA, Tirtayasa PMW, Situmorang GR, Rasyid N, Rodjani A, Daryanto B, Seputra KP, Satyagraha P. Predictor factor for worse outcomes in kidney transplant recipients infected with coronavirus disease 2019: A systematic review and meta-analysis. Transpl Immunol 2023;76:101739. [PMID: 36414181 DOI: 10.1016/j.trim.2022.101739] [Reference Citation Analysis]
4 Chertok Shacham E, Maman N, Ishay A. Blood glucose control with different treatment regimens in type 2 diabetes patients hospitalized with COVID-19 infection: A retrospective study. Medicine (Baltimore) 2023;102:e32650. [PMID: 36701712 DOI: 10.1097/MD.0000000000032650] [Reference Citation Analysis]
5 Pinchera B, Schiano Moriello N, Buonomo AR, Di Filippo I, Tanzillo A, Buzzo G, Villari R, Gentile I, Federico Ii Covid Team. Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19. Microorganisms 2023;11. [PMID: 36677437 DOI: 10.3390/microorganisms11010145] [Reference Citation Analysis]
6 Mahalakshmi R, Lalithamani N. Preventing COVID-19 Using Edge Intelligence in Internet of Medical Things. International Conference on Innovative Computing and Communications 2023. [DOI: 10.1007/978-981-19-2821-5_18] [Reference Citation Analysis]
7 Gordon C, Kamel B, McKeon L, Brooks D, Schulman-Rosenbaum R. Dexamethasone use and insulin requirements in coronovirus-19 (COVID-19) infection stratified by Hemoglobin A1c. Diabet Epidemiol Manag 2023;10:100123. [PMID: 36514311 DOI: 10.1016/j.deman.2022.100123] [Reference Citation Analysis]
8 Barmanray RD, Gong JY, Kyi M, Kevat D, Islam MA, Galligan A, Manos GR, Nair IV, Perera N, Adams NK, Nursing A, Warren AM, Hamblin PS, MacIsaac RJ, Ekinci EI, Krishnamurthy B, Karunajeewa H, Buising K, Visvanathan K, Kay TWH, Fourlanos S. Diabetes IN hospital - Glucose and Outcomes in the COVID-19 pandemic (DINGO COVID-19): the 2020 Melbourne hospital experience prior to novel variants and vaccinations. Intern Med J 2023;53:27-36. [PMID: 36269315 DOI: 10.1111/imj.15937] [Reference Citation Analysis]
9 Matias AA, Manique I, Sabino T, Rego T, Mihon C, Panarra A, Rizzo M, Silva-Nunes J. Absolute Hyperglycemia versus Stress Hyperglycemia Ratio for the Prognosis of Hospitalized Patients with COVID-19 in the First Months of the Pandemic: A Retrospective Study. Diabetes Ther 2022;:1-12. [PMID: 36574200 DOI: 10.1007/s13300-022-01347-4] [Reference Citation Analysis]
10 Dumitrascu AG, Perry MF, Boone RJ, Guzman MP, Chirila RM, McNally AW, Colibaseanu DT, Meek SE, Ball CT, White LJ, Chindris AM. Continuous Glucose Monitoring for Patients with COVID-19 Pneumonia: Initial Experience at a Tertiary Care Center. Endocr Pract 2022:S1530-891X(22)00902-8. [PMID: 36566985 DOI: 10.1016/j.eprac.2022.12.012] [Reference Citation Analysis]
11 Kasatwar A, Shukla R, Rathod N, Nandanwar J, Mishra D, Dhobley A. Insights from Surgically treated Post Covid Acute Invasive Fungal Rhino-Orbital sinusitis in Chandrapur Study (SPAROS): A Population Based study of Coronavirus Associated Mucormycosis (CAM) characteristics in India. IJID Regions 2022;5:21-29. [DOI: 10.1016/j.ijregi.2022.08.005] [Reference Citation Analysis]
12 Miguélez M, Velasco C, Camblor M, Cedeño J, Serrano C, Bretón I, Arhip L, Motilla M, Carrascal ML, Olivares P, Morales A, Brox N, Cuerda C. Nutritional management and clinical outcome of critically ill patients with COVID-19: A retrospective study in a tertiary hospital. Clin Nutr 2022;41:2940-6. [PMID: 34782169 DOI: 10.1016/j.clnu.2021.10.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
13 Cheung NW, Gilroy N, Hor A, Jose S, Kairaitis K, Nayyar V, O'Sullivan MVN, Wheatley J, Chipps DR. Diabetes and hyperglycaemia among hospitalised patients with COVID-19 in Western Sydney: a retrospective cohort study. Intern Med J 2022. [PMID: 36369676 DOI: 10.1111/imj.15975] [Reference Citation Analysis]
14 Vinod DN, Lebekwe CK, Zungeru AM, Menaka D. Correlation and Causation in the Perspective of COVID-19: An Empirical Study on Canonical Correlation Analysis. 2022 International Conference on Smart Applications, Communications and Networking (SmartNets) 2022. [DOI: 10.1109/smartnets55823.2022.9993985] [Reference Citation Analysis]
15 Hardy YO, Libhaber E, Ofori E, Amenuke DAY, Kontoh SA, Dankwah JA, Larsen-Reindorf R, Otu-Ansah C, Hutton-Mensah K, Dadson E, Adamu S, Akyerekoh K, Sarfo FS, Nkum B. Clinical and laboratory profile and outcomes of hospitalized COVID-19 patients with type 2 diabetes mellitus in Ghana - A single-center study. Endocrinol Diabetes Metab 2023;6:e391. [PMID: 36426913 DOI: 10.1002/edm2.391] [Reference Citation Analysis]
16 Tolossa T, Lema M, Wakuma B, Turi E, Fekadu G, Mulisa D, Fetensa G. Incidence and predictors of diabetes mellitus among severe COVID-19 patients in western Ethiopia: a retrospective cohort study. Journal of Endocrinology, Metabolism and Diabetes of South Africa 2022. [DOI: 10.1080/16089677.2022.2144016] [Reference Citation Analysis]
17 Madaschi S, Resmini E, Bonfadini S, Massari G, Gamba P, Sandri M, Calza S, Cimino E, Zarra E, Dotti S, Mascadri C, Agosti B, Garrafa E, Girelli A. Predictive markers for clinical outcomes in a cohort of diabetic patients hospitalized for COVID-19. Diabetol Metab Syndr 2022;14:168. [DOI: 10.1186/s13098-022-00941-7] [Reference Citation Analysis]
18 Santos AACD, Rodrigues LE, Alecrim-zeza AL, de Araújo Ferreira L, Trettel CDS, Gimenes GM, Silva AFD, Sousa-filho CPB, Serdan TDA, Levada-pires AC, Hatanaka E, Borges FT, de Barros MP, Cury-boaventura MF, Bertolini GL, Cassolla P, Marzuca-nassr GN, Vitzel KF, Pithon-curi TC, Masi LN, Curi R, Gorjao R, Hirabara SM. Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1037467] [Reference Citation Analysis]
19 Alkouri O, Khader Y, Hweidi IM, Gharaibeh MK, Jarrah M, Hamdan KM, Al Marzouqi A, Khamaiseh K. COVID-19 Fear and Anxiety among Patients with Chronic Heart Failure: A Cross Sectional Study. JCM 2022;11:6586. [DOI: 10.3390/jcm11216586] [Reference Citation Analysis]
20 Lombardi A, Agarwal S, Schechter C, Tomer Y. In-Hospital Hyperglycemia Is Associated With Worse Outcomes in Patients Admitted With COVID-19. Diabetes Care 2022;45:2683-8. [PMID: 36041197 DOI: 10.2337/dc22-0708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Bhat MJ, Almaker YA, Algarni AS, Alashqan ZM, Aljarallah FAM, AlIbrahim A, Alshehri TK, Al-Asmari ZS, Alshahrani A, Alsalem A, Alfaifi AH, Hammad AM. Effect of Uncomplicated Diabetes Mellitus on Acute Respiratory Distress Syndrome Among COVID-19 Patients in Aseer Region, Saudi Arabia. Cureus 2022;14:e31793. [PMID: 36569667 DOI: 10.7759/cureus.31793] [Reference Citation Analysis]
22 Woodayagiri S, Moorthy S, Bhaskar E, Marappa L. Bedside Scoring System for Predicting Adverse Outcomes Among Patients Suffering From SARS-CoV-2 Infection. Cureus 2022;14:e32009. [PMID: 36589201 DOI: 10.7759/cureus.32009] [Reference Citation Analysis]
23 Bhagat A, Buxton L, Hasan M. Correlation Between HbA1c Levels and Mortality Rates in Hospitalized COVID-19 Patients. Cureus 2022. [DOI: 10.7759/cureus.31347] [Reference Citation Analysis]
24 Mustafa M, Attaallah A, Amir O, Elbalal M, Gibriel AAA. The characteristics and outcomes of COVID-19 among diabetic patients in Wad-Medani isolation center from September to December 2020: A cross-sectional study. Health Sci Rep 2022;5:e889. [PMID: 36324424 DOI: 10.1002/hsr2.889] [Reference Citation Analysis]
25 Djusad S, Irwinda R, Harzif AK, Surya R, Wibowo N, Saroyo YB, Adjie JS. Determining laboratory parameters in pregnant women with severe COVID-19. SAGE Open Med 2022;10:20503121221132168. [PMID: 36277440 DOI: 10.1177/20503121221132168] [Reference Citation Analysis]
26 Medimpudi S, Medimpudi L, Ayyagari LR, Araveti J, Kadiri M. A study of changing trends in consumer preferences and perspectives towards health-care services during the pandemic. IJPP 2022;66:168-174. [DOI: 10.25259/ijpp_454_2021] [Reference Citation Analysis]
27 Blonde L, Umpierrez GE, Reddy SS, McGill JB, Berga SL, Bush M, Chandrasekaran S, DeFronzo RA, Einhorn D, Galindo RJ, Gardner TW, Garg R, Garvey WT, Hirsch IB, Hurley DL, Izuora K, Kosiborod M, Olson D, Patel SB, Pop-Busui R, Sadhu AR, Samson SL, Stec C, Tamborlane WV Jr, Tuttle KR, Twining C, Vella A, Vellanki P, Weber SL. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. Endocr Pract 2022;28:923-1049. [PMID: 35963508 DOI: 10.1016/j.eprac.2022.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
28 Keerthi BY, Sushmita G, Khan EA, Thomas V, Cheryala V, Shah C, Kumar GR, Haritha V. New onset diabetes mellitus in post-COVID-19 patients. J Family Med Prim Care 2022;11:5961-8. [PMID: 36618178 DOI: 10.4103/jfmpc.jfmpc_316_22] [Reference Citation Analysis]
29 Fukushima T, Chubachi S, Namkoong H, Asakura T, Tanaka H, Lee H, Azekawa S, Okada Y, Koike R, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K; Japan COVID-19 Task Force. Clinical significance of prediabetes, undiagnosed diabetes and diagnosed diabetes on critical outcomes in COVID-19: Integrative analysis from the Japan COVID-19 task force. Diabetes Obes Metab 2023;25:144-55. [PMID: 36056760 DOI: 10.1111/dom.14857] [Reference Citation Analysis]
30 Eseadi C, Ossai OV, Onyishi CN, Ilechukwu LC. Assisting individuals with diabetes in the COVID-19 pandemic period: Examining the role of religious factors and faith communities. World J Clin Cases 2022; 10(26): 9180-9191 [DOI: 10.12998/wjcc.v10.i26.9180] [Reference Citation Analysis]
31 Vasilev G, Kabakchieva P, Miteva D, Batselova H, Velikova T. Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy. World J Diabetes 2022; 13(9): 738-751 [DOI: 10.4239/wjd.v13.i9.738] [Reference Citation Analysis]
32 Gavkare AM, Nanaware N, Rayate AS, Mumbre S, Nagoba BS. COVID-19 associated diabetes mellitus: A review. World J Diabetes 2022; 13(9): 729-737 [DOI: 10.4239/wjd.v13.i9.729] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
33 Shi Y, Wu LQ, Wei P, Liao ZH. Children with type 1 diabetes in COVID-19 pandemic: Difficulties and solutions. World J Clin Pediatr 2022; 11(5): 408-418 [DOI: 10.5409/wjcp.v11.i5.408] [Reference Citation Analysis]
34 Zulueta M, Aurrekoetxea J, Mendizabal L, Gaztambide S, Arregi M, Hoz AB, Arana-arri E, Saso L, Gomez-conde S, Martinez-salazar R, Urrutia I, Sanchez-moran M, Garcia-castaño A, Pérez-nanclares G, Velasco O, Calvo B, Simon L, Castaño L. Severe COVID-19 in the Basque Country, Spain: Risk Prediction Model with Genetic and Clinical Factors.. [DOI: 10.21203/rs.3.rs-2015865/v1] [Reference Citation Analysis]
35 Milani P, Torres-aguilar P, Hamaker B, Manary M, Abushamma S, Laar A, Steiner R, Ehsani M, de la Parra J, Skaven-ruben D, de Kock H, Hawkes C, Covic N, Mitchell C, Taylor J. The whole grain manifesto: From Green Revolution to Grain Evolution. Global Food Security 2022;34:100649. [DOI: 10.1016/j.gfs.2022.100649] [Reference Citation Analysis]
36 Alipour M, Javeshghani D, Roustazadeh A. Gene expression pattern in severely progressing covid-19 patients is related to diabetes mellitus type 1: A functional annotation analysis. Human Gene 2022;33:201039. [DOI: 10.1016/j.humgen.2022.201039] [Reference Citation Analysis]
37 Kodani N, Ohsugi M. The patient-centered diabetes management during the COVID-19 pandemic. GHM 2022;4:210-215. [DOI: 10.35772/ghm.2022.01031] [Reference Citation Analysis]
38 Dalia G, Vaiera Manigandan AC, Rangabashyam SR. Glycosylated Hemoglobin as an Independent Prognostic Marker in COVID-19 Patients With Diabetes Mellitus. Cureus 2022. [DOI: 10.7759/cureus.28634] [Reference Citation Analysis]
39 Dandachi I, Aljabr W. Prognosis of COVID-19 in the middle eastern population, knowns and unknowns. Front Microbiol 2022;13:974205. [DOI: 10.3389/fmicb.2022.974205] [Reference Citation Analysis]
40 Bhadada SK, Pal R. Diabetes Mellitus and COVID-19. COVID-19: Effects in Comorbidities and Special Populations 2022. [DOI: 10.2174/9789815036367122010004] [Reference Citation Analysis]
41 Beyh YS, Sachdeva R, Narayan KM, Bhasin M. SARS-CoV-2 and Co-morbidities. COVID-19: Effects in Comorbidities and Special Populations 2022. [DOI: 10.2174/9789815036367122010003] [Reference Citation Analysis]
42 Rey-reñones C, Martinez-torres S, Martín-luján FM, Pericas C, Redondo A, Vilaplana-carnerero C, Dominguez A, Grau M. Type 2 Diabetes Mellitus and COVID-19: A Narrative Review. Biomedicines 2022;10:2089. [DOI: 10.3390/biomedicines10092089] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Erman H, Boyuk B, Sertbas M, Ozdemir A. Relationship between Metabolic Syndrome Components and COVID-19 Disease Severity in Hospitalized Patients: A Pilot Study. Canadian Journal of Infectious Diseases and Medical Microbiology 2022;2022:1-7. [DOI: 10.1155/2022/9682032] [Reference Citation Analysis]
44 Sinagra E, Shahini E, Crispino F, Macaione I, Guarnotta V, Marasà M, Testai S, Pallio S, Albano D, Facciorusso A, Maida M. COVID-19 and the Pancreas: A Narrative Review. Life 2022;12:1292. [DOI: 10.3390/life12091292] [Reference Citation Analysis]
45 I T, Tsai Y, Cheng Y. Predictors of Basic Activity in Daily Living and Length of Hospitalization in Patients with COVID-19. Healthcare 2022;10:1589. [DOI: 10.3390/healthcare10081589] [Reference Citation Analysis]
46 Pelle MC, Zaffina I, Provenzano M, Moirano G, Arturi F. COVID-19 and diabetes—Two giants colliding: From pathophysiology to management. Front Endocrinol 2022;13:974540. [DOI: 10.3389/fendo.2022.974540] [Reference Citation Analysis]
47 Menekli T, Yaprak B, Türeyen A, Şentürk S. Investigation of COVID-19 fear, treatment compliance, and metabolic control of patients with type 2 diabetes mellitus during the pandemic. Prim Care Diabetes 2022:S1751-9918(22)00134-6. [PMID: 36030171 DOI: 10.1016/j.pcd.2022.08.005] [Reference Citation Analysis]
48 Eyitemi J, Thomas B, Ramos Y, Feng X, Ezekwesili C. SARS-CoV-2: Review of Conditions Associated With Severe Disease and Mortality. Int J Prev Med 2022;13:109. [PMID: 36247195 DOI: 10.4103/ijpvm.IJPVM_640_20] [Reference Citation Analysis]
49 Le VT, Ha QH, Tran MT, Le NT, Le VT, Le MK. Hyperglycemia in Severe and Critical COVID-19 Patients: Risk Factors and Outcomes. Cureus 2022. [DOI: 10.7759/cureus.27611] [Reference Citation Analysis]
50 Gómez-huelgas R, Gómez-peralta F. Perceptions about the Management of Patients with DM2 and COVID-19 in the Hospital Care Setting. JCM 2022;11:4507. [DOI: 10.3390/jcm11154507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Chandrashekhar Joshi S, Pozzilli P. COVID-19 Induced Diabetes: A Novel Presentation. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.110034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Kerolos MM, Ruge M, Gill A, Planek MI, Volgman AS, Du-fay-de-lavallaz JM, Gomez JMD, Suboc TM, Williams KA, Abusin S. Clinical outcomes of COVID-19 infection in patients with pre-existing cardiovascular disease. American Heart Journal Plus: Cardiology Research and Practice 2022;20:100189. [DOI: 10.1016/j.ahjo.2022.100189] [Reference Citation Analysis]
53 Skwiersky S, Rosengarten S, Meisel T, Macaluso F, Chang M, Thomson A, Da Silva B, Oommen A, Salvani J, Banerji MA. Sugar is not always sweet: exploring the relationship between hyperglycemia and COVID-19 in a predominantly African American population. BMJ Open Diabetes Res Care 2022;10:e002692. [PMID: 36002176 DOI: 10.1136/bmjdrc-2021-002692] [Reference Citation Analysis]
54 Boeder S, Kobayashi E, Ramesh G, Serences B, Kulasa K, Majithia AR. Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: A Retrospective Study. J Diabetes Sci Technol. [DOI: 10.1177/19322968221113865] [Reference Citation Analysis]
55 Schroeder PH, Brenner LN, Kaur V, Cromer SJ, Armstrong K, LaRocque RC, Ryan ET, Meigs JB, Florez JC, Charles RC, Mercader JM, Leong A. Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19. Cardiovasc Diabetol 2022;21:136. [PMID: 35864532 DOI: 10.1186/s12933-022-01569-7] [Reference Citation Analysis]
56 Klonoff DC, Nguyen KT, Xu NY, Gutierrez A, Espinoza JC, Vidmar AP. Use of Continuous Glucose Monitors by People Without Diabetes: An Idea Whose Time Has Come? J Diabetes Sci Technol 2022;:19322968221110830. [PMID: 35856435 DOI: 10.1177/19322968221110830] [Reference Citation Analysis]
57 Sono-setati ME, Mphekgwana PM, Mabila LN, Mbombi MO, Muthelo L, Matlala SF, Tshitangano TG, Ramalivhana NJ. Health System- and Patient-Related Factors Associated with COVID-19 Mortality among Hospitalized Patients in Limpopo Province of South Africa’s Public Hospitals. Healthcare 2022;10:1338. [DOI: 10.3390/healthcare10071338] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Gaba U, Altamish M, Azharuddin M, Adil M, Ghosh P, Gyawali B, Yadav Y, Sharma M. Risk factors and outcomes associated with diabetes mellitus in COVID-19 patients: a meta-analytic synthesis of observational studies. J Diabetes Metab Disord. [DOI: 10.1007/s40200-022-01072-6] [Reference Citation Analysis]
59 Huang XY, Yang LJ, Hu X, Zhang XX, Gu X, Du LJ, He ZY, Gu XJ. Elevated levels of fructosamine are independently associated with SARS-CoV-2 reinfection: A 12-mo follow-up study. World J Diabetes 2022; 13(7): 543-552 [DOI: 10.4239/wjd.v13.i7.543] [Reference Citation Analysis]
60 Vedantam D, Poman DS, Motwani L, Asif N, Patel A, Anne KK. Stress-Induced Hyperglycemia: Consequences and Management. Cureus 2022. [DOI: 10.7759/cureus.26714] [Reference Citation Analysis]
61 Bajpeyi S, Mossayebi A, Kreit H, Cherukuri S, Mandania RA, Concha JB, Jung H, Wagler A, Gupte A, Deoker A. Unmanaged Diabetes and Elevated Blood Glucose Are Poor Prognostic Factors in the Severity and Recovery Time in Predominantly Hispanic Hospitalized COVID-19 Patients. Front Endocrinol 2022;13:861385. [DOI: 10.3389/fendo.2022.861385] [Reference Citation Analysis]
62 Rai H, Saad T, Rawat S, Mishra N, Mishra S. IS COVID 19 PANDEMIC ADDING MORE OF DIABETIC POPULATION: A STUDY IN CENTRAL INDIA. IJAR 2022. [DOI: 10.36106/ijar/4002154] [Reference Citation Analysis]
63 Barmanray RD, Cheuk N, Fourlanos S, Greenberg PB, Colman PG, Worth LJ. In-hospital hyperglycemia but not diabetes mellitus alone is associated with increased in-hospital mortality in community-acquired pneumonia (CAP): a systematic review and meta-analysis of observational studies prior to COVID-19. BMJ Open Diabetes Res Care 2022;10:e002880. [PMID: 35790320 DOI: 10.1136/bmjdrc-2022-002880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Sayed AA, Abdelfatah HH, Abdelhameid MA, Ali OM. Different Aspects of Diabetes in Hospitalized Patients with COVID-19. Int J Gen Med 2022;15:5729-40. [PMID: 35761893 DOI: 10.2147/IJGM.S360160] [Reference Citation Analysis]
65 Robeva R, Petrova D, Elenkova A, Tankova T, Zacharieva S. C-peptide levels and glycemic indices in COVID-19 patients. Biotechnology & Biotechnological Equipment 2022;36:418-424. [DOI: 10.1080/13102818.2022.2090858] [Reference Citation Analysis]
66 Jedrzejak AP, Urbaniak EK, Wasko JA, Ziojla N, Borowiak M. Diabetes and SARS-CoV-2–Is There a Mutual Connection? Front Cell Dev Biol 2022;10:913305. [DOI: 10.3389/fcell.2022.913305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Krishnasamy S, Sheikh D, Ali T, Clemons V, Furmanek S, Mohamed Fawzy Abdelhaleem AA, Salunkhe V, Akbar UA, Chlebowy D, Ramirez J, Arnold F. Impact of hyperglycemia on cardiovascular events and clinical outcomes in patients hospitalized with COVID-19 pneumonia. Endocrine Practice 2022. [DOI: 10.1016/j.eprac.2022.05.011] [Reference Citation Analysis]
68 Valle A, Rodriguez J, Camiña F, Martínez-olmos MA, Ortola JB, Rodriguez-segade S. At-admission HbA1c levels in Hospitalized COVID-19 Participants With and Without Known Diabetes. Clinica Chimica Acta 2022. [DOI: 10.1016/j.cca.2022.05.027] [Reference Citation Analysis]
69 Choudhary P, Kao K, Dunn TC, Brandner L, Rayman G, Wilmot EG. Glycaemic measures for 8914 adult FreeStyle Libre users during routine care, segmented by age group and observed changes during the COVID-19 pandemic. Diabetes Obes Metab 2022. [PMID: 35638378 DOI: 10.1111/dom.14782] [Reference Citation Analysis]
70 Gęca T, Wojtowicz K, Guzik P, Góra T. Increased Risk of COVID-19 in Patients with Diabetes Mellitus-Current Challenges in Pathophysiology, Treatment and Prevention. Int J Environ Res Public Health 2022;19:6555. [PMID: 35682137 DOI: 10.3390/ijerph19116555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
71 Degarege A, Naveed Z, Kabayundo J, Brett-Major D. Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis. Pathogens 2022;11. [PMID: 35631084 DOI: 10.3390/pathogens11050563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
72 Boeder S, Kobayashi E, Ramesh G, Serences B, Kulasa K, Majithia AR. Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: a Retrospective Study.. [DOI: 10.1101/2022.05.06.22274685] [Reference Citation Analysis]
73 Plummer MP, Rait L, Finnis ME, French CJ, Bates Ccrn S, Douglas J, Bhurani M, Broadley T, Trapani T, Deane AM, Udy AA, Burrell AJ, Burrell A, Cheng A, Udy A, Palermo A, Reddi B, Reynolds C, French C, Cooper DJ, Litton E, Begum H, Campbell L, Ramanan M, Plummer M, Mcallister R, Erickson S, Broadley T, Trapani T, Cheung W, Sprint-sari Australia Investigators T, Visser A, Mattke A, Regli A, Rashid A, Tabah A, Walker A, Cheng A, Corley A, Udy A, Ramnani A, Eidan A, Dekeulenaer B, Reddi B, Richards B, Knott C, Moore C, Delzoppo C, Boschert C, Tacon C, French C, Austin D, Brewster D, Cooper D, Crosbie D, Hawkins D, Jessen E, Martinez E, Fysh E, Litton E, Oberender F, Mcgain F, Salt G, Eastwood G, Taori G, White H, Buscher H, Seppelt I, Leditschke IA, Young J, Lavana J, Cohen J, Lugsdin J, Botha J, Santamaria J, Barrett J, Singh K, Laupland K, El-khawas K, Estensen K, Deshpande K, White K, Fitzpatrick L, Campbell L, Ramanan M, Saxena M, Kainer M, Kol M, Page M, Plummer M, Sterba M, Anstey M, Brain M, Maiden M, Kilminster M, Hammond N, Bhadange N, Humphreys N, Jain P, Azzi P, Secombe P, Lister P, Chan P, Mccanny P, Britton P, Janin P, Krishnamurthy R, Sonawane R, Tiruvoipati R, Totaro R, Bellomo R, Sanghavi R, Bates S, Peake S, Bihari S, George S, Erickson S, Webb S, Arora S, Ganu S, Rozen T, Mckenna T, Kadam U, Nayyar V, Choy WH, Albassam W, Data entry at the nested cohort sites, Morgan R, Prasad L, Carstens L, Bates S, Rait L, Bhurani M. Diabetes mellitus, glycaemic control and severe COVID-19 in the Australian Critical Care Setting – a nested cohort study. Australian Critical Care 2022. [DOI: 10.1016/j.aucc.2022.05.002] [Reference Citation Analysis]
74 Kastora S, Patel M, Carter B, Delibegovic M, Myint PK. Impact of diabetes on COVID-19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta-analysis. Endocrinol Diabetes Metab 2022;5:e00338. [PMID: 35441801 DOI: 10.1002/edm2.338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
75 Tazare J, Walker AJ, Tomlinson L, Hickman G, Rentsch CT, Williamson EJ, Bhaskaran K, Evans D, Wing K, Mathur R, Wong AY, Schultze A, Bacon S, Bates C, Morton CE, Curtis HJ, Nightingale E, Mcdonald HI, Mehrkar A, Inglesby P, Davy S, Mackenna B, Cockburn J, Hulme WJ, Warren-gash C, Bhate K, Nitsch D, Powell E, Mulick A, Forbes H, Minassian C, Croker R, Parry J, Hester F, Harper S, Eggo RM, Evans SJ, Smeeth L, Douglas IJ, Goldacre B; The OpenSAFELY Collaborative. Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19 in England: a descriptive cohort study within the OpenSAFELY platform. Wellcome Open Res 2022;7:142. [DOI: 10.12688/wellcomeopenres.17735.1] [Reference Citation Analysis]
76 Yilmaz Phd. Rn, Associate Prof FT, Cetindag Ciltas A. Prevalence of COVID-19 Infection in Type 2 Diabetes Patients and Their Anxiety Levels. Prog Health Sci 2022;12:66-74. [DOI: 10.5604/01.3001.0015.8835] [Reference Citation Analysis]
77 Gerganova A, Assyov Y, Kamenov Z. Stress Hyperglycemia, Diabetes Mellitus and COVID-19 Infection: Risk Factors, Clinical Outcomes and Post-Discharge Implications. Front Clin Diabetes Healthc 2022;3. [DOI: 10.3389/fcdhc.2022.826006] [Reference Citation Analysis]
78 Alharbi AA, Alqumaizi KI, Bin Hussain I, Alharbi NS, Alqahtani A, Alzawad W, Suhail HM, Alameer MI, Alharbi MA, Alzamanan H. Hospital Length of Stay and Related Factors for COVID-19 Inpatients Among the Four Southern Regions Under the Proposed Southern Business Unit of Saudi Arabia. JMDH 2022;Volume 15:825-36. [DOI: 10.2147/jmdh.s362625] [Reference Citation Analysis]
79 Pinchera B, Scotto R, Buonomo AR, Zappulo E, Stagnaro F, Gallicchio A, Viceconte G, Sardanelli A, Mercinelli S, Villari R, Foggia M, Gentile I; Federico II COVID Team. Diabetes and COVID-19: The potential role of mTOR. Diabetes Res Clin Pract 2022;186:109813. [PMID: 35248653 DOI: 10.1016/j.diabres.2022.109813] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
80 Mustafina SV, Kashirina AP. Сахарный диабет у пожилых пациентов в условиях новой коронавирусной инфекции (COVID-19) . Rossiiskii zhurnal geriatricheskoi meditsiny 2022. [DOI: 10.37586/2686-8636-4-2021-414-419] [Reference Citation Analysis]
81 Dedov II, Mokrysheva NG, Shestakova MV, Nikonova TV, Mayorov AY, Galstyan GR, Shamhalova MS, Barysheva VO, Ametov AS, Antsiferov MB, Babenko AY, Bardymova TP, Valeeva FV, Vachugova AA, Grineva EN, Demidova TY, Kiseleva TP, Kunicyna MA, Markova TN, Mkrtumyan AM, Petunina NA, Ruyatkina LA, Saluhov VV, Suplotova LA, Hadarceva EL, Halimov YS. Glycemia control and choice of antihyperglycemic therapy in patients with type 2 diabetes mellitus and COVID-19: a consensus decision of the board of experts of the Russian association of endocrinologists. Diabetes mellitus 2022;25:27-49. [DOI: 10.14341/dm12873] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Matsumori A. Novel Biomarkers of Inflammation for the Management of Diabetes: Immunoglobulin-Free Light Chains. Biomedicines 2022;10:666. [DOI: 10.3390/biomedicines10030666] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
83 Tzeravini E, Stratigakos E, Siafarikas C, Tentolouris A, Tentolouris N. The Role of Diabetes and Hyperglycemia on COVID-19 Infection Course—A Narrative Review. Front Clin Diabetes Healthc 2022;3. [DOI: 10.3389/fcdhc.2022.812134] [Reference Citation Analysis]
84 Wong CKH, Lui DTW, Lui AYC, Low MCH, Kwok ACY, Lau KTK, Au ICH, Xiong X, Chung MSH, Lau EHY, Cowling BJ. Metformin Use in Relation to Clinical Outcomes and Hyperinflammatory Syndrome Among COVID-19 Patients With Type 2 Diabetes: A Propensity Score Analysis of a Territory-Wide Cohort. Front Endocrinol 2022;13:810914. [DOI: 10.3389/fendo.2022.810914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Yonekawa A, Shimono N. Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron (B.1.1.529). Biology (Basel) 2022;11:400. [PMID: 35336774 DOI: 10.3390/biology11030400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
86 Mendes TB, Câmara-de-Souza AB, Halpern B. Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerations. Diabetol Metab Syndr 2022;14:37. [PMID: 35246230 DOI: 10.1186/s13098-022-00808-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
87 Mirabella S, Gomez-Paz S, Lam E, Gonzalez-Mosquera L, Fogel J, Rubinstein S. Glucose dysregulation and its association with COVID-19 mortality and hospital length of stay. Diabetes Metab Syndr 2022;16:102439. [PMID: 35255293 DOI: 10.1016/j.dsx.2022.102439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Nateghi S, Gomari MM, roudsari YJ, Foroughi A, Mansouri F, Shiva A, Nasrollahizadeh A, Nasiri Z, Faraji N. Moderately hyperglycemia as an independent prognostic factor for the worse outcome of COVID-19. Primary Care Diabetes 2022. [DOI: 10.1016/j.pcd.2022.03.005] [Reference Citation Analysis]
89 Corcillo A, Saqib A, Sithamparanathan N, Khanam A, Williams J, Gulati A, Kariyawasam D, Karalliedde J, Pitocco D. Clinical Features and Changes in Insulin Requirements in People with Type 2 Diabetes Requiring Insulin When Hospitalised with SARS-CoV-2 Infection. International Journal of Endocrinology 2022;2022:1-6. [DOI: 10.1155/2022/8030765] [Reference Citation Analysis]
90 Liu A, Raja xavier J, Singh Y, Brucker SY, Salker MS. Molecular and Physiological Aspects of SARS-CoV-2 Infection in Women and Pregnancy. Front Glob Womens Health 2022;3:756362. [DOI: 10.3389/fgwh.2022.756362] [Reference Citation Analysis]
91 Strongin LG, Nekrasova TA, Belikina DV, Korneva KG, Petrov AV. [Dysglycemia in COVID-19 and Type 2 Diabetes Mellitus: Peculiarities of the Glycemic Profile in Hospitalized Patients and the Role of Steroid-Induced Disorders]. Probl Endokrinol (Mosk) 2022;68:56-65. [PMID: 35488757 DOI: 10.14341/probl12840] [Reference Citation Analysis]
92 Kazakou P, Lambadiari V, Ikonomidis I, Kountouri A, Panagopoulos G, Athanasopoulos S, Korompoki E, Kalomenidis I, Dimopoulos MA, Mitrakou A. Diabetes and COVID-19; A Bidirectional Interplay. Front Endocrinol 2022;13:780663. [DOI: 10.3389/fendo.2022.780663] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
93 Strongin LG, Korneva KG, Petrov AV, Nekrasova TA, Mavia EA, Belikina DV, Malysheva ES, Melnichenko OV. Features of COVID-19 course in patients with obesity and dysglycemia. Russ J Cardiol 2022;27:4835. [DOI: 10.15829/1560-4071-2022-4835] [Reference Citation Analysis]
94 Zaki MO, Elsherbiny DA, Salama M, Azab SS. Potential role of Drug Repositioning Strategy (DRS) for management of tauopathy. Life Sci 2022;291:120267. [PMID: 34974076 DOI: 10.1016/j.lfs.2021.120267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
95 Zambelli L, Pegreffi F. EU health co-design policies to counteract the covid-19 pandemic effect promoting physical activity. Int J Risk Saf Med 2022. [PMID: 35147565 DOI: 10.3233/JRS-227012] [Reference Citation Analysis]
96 Steenblock C, Ludwig B, Bornstein S. Kann Diabetes durch COVID-19 ausgelöst werden? Diabetes aktuell 2022;20:12-17. [DOI: 10.1055/a-1749-2969] [Reference Citation Analysis]
97 Hussein HJ, Ibrahim SA, Al-Shaibani SW, Abdulrudha NH. Association of Covid-19 with blood type A in relation to blood sugar, urea, and blood test (D-dimer and ferritin) in patients from Al-Najaf. J Med Life 2022;15:180-7. [PMID: 35419105 DOI: 10.25122/jml-2021-0239] [Reference Citation Analysis]
98 Oriot P, Hermans MP. Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case-report and review of the literature. Acta Clin Belg 2022;77:113-7. [PMID: 32544373 DOI: 10.1080/17843286.2020.1780390] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 18.0] [Reference Citation Analysis]
99 Singh AK, Khunti K. COVID-19 and Diabetes. Annu Rev Med 2022;73:129-147. [DOI: 10.1146/annurev-med-042220-011857] [Cited by in Crossref: 11] [Article Influence: 11.0] [Reference Citation Analysis]
100 Llanera DK, Wilmington R, Shoo H, Lisboa P, Jarman I, Wong S, Nizza J, Sharma D, Kalathil D, Rajeev S, Williams S, Yadav R, Qureshi Z, Narayanan RP, Furlong N, Westall S, Nair S. Clinical Characteristics of COVID-19 Patients in a Regional Population With Diabetes Mellitus: The ACCREDIT Study. Front Endocrinol 2022;12:777130. [DOI: 10.3389/fendo.2021.777130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Endo K, Miki T, Itoh T, Kubo H, Ito R, Ohno K, Hotta H, Kato N, Matsumoto T, Kitamura A, Tamayama M, Wataya T, Yamaya A, Ishikawa R, Ooiwa H. Impact of the COVID-19 Pandemic on Glycemic Control and Blood Pressure Control in Patients with Diabetes in Japan. Intern Med 2022;61:37-48. [PMID: 34980759 DOI: 10.2169/internalmedicine.8041-21] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
102 Bhikoo R, Conradie-smit M, Van Wyk G, Lahri S, Du Plessis E, Cilliers J, Hugo S, Coetzee A. COVID-19 and hyperglycaemic emergencies: perspectives from a developing country. Journal of Endocrinology, Metabolism and Diabetes of South Africa 2022;27:42-48. [DOI: 10.1080/16089677.2021.1939934] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Ikram A, Pillay S. Hyperglycaemia, diabetes mellitus and COVID-19 in a tertiary hospital in KwaZulu-Natal. Journal of Endocrinology, Metabolism and Diabetes of South Africa 2022;27:32-41. [DOI: 10.1080/16089677.2021.1997427] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Katsiki N, Banach M. Antidiabetic Drugs in COVID-19. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-031-15478-2_21] [Reference Citation Analysis]
105 Mukai K, Ohshita K, Yamashita K, Misuiri S, Shigemoto K, Nishizawa Y, Doi T, Masaki T. Use of flash glucose monitoring for blood glucose control in three diabetes patients undergoing maintenance hemodialysis who were hospitalized for COVID‒19 pneumonia. Nihon Toseki Igakkai Zasshi 2022;55:255-264. [DOI: 10.4009/jsdt.55.255] [Reference Citation Analysis]
106 Njemanze P, Mgbenu C, Darlington C, Ofoegbu C, Ukeje N, Ohaegbulem I, Nneke E, Onuchukwu J, Ukaegbu C, Amuchie M, Mezu C, Anaele J, Uzoma O, Mbara C, Amadi A, Iwuagwu B. Hypercoagulable state in COVID-19 and diabetes: Cerebral vasospasm, intracardiac clot, and pulmonary embolism. Niger J Gen Pract 2022;20:6. [DOI: 10.4103/njgp.njgp_3_22] [Reference Citation Analysis]
107 Mallick U. Diabetes Mellitus and COVID19. Cardiovascular Complications of COVID-19 2022. [DOI: 10.1007/978-3-030-90065-6_16] [Reference Citation Analysis]
108 Robbins T, Hopper A, Brophy J, Pearson E, Suthantirakumar R, Vankad M, Igharo N, Baitule S, Clark CC, Arvanitis TN, Sankar S, Kyrou I, Randeva H. Digitally enabled flash glucose monitoring for inpatients with COVID-19: Feasibility and pilot implementation in a teaching NHS Hospital in the UK. DIGITAL HEALTH 2022;8:205520762110593. [DOI: 10.1177/20552076211059350] [Reference Citation Analysis]
109 Mallick U. The Older Age Adults and COVID19. Cardiovascular Complications of COVID-19 2022. [DOI: 10.1007/978-3-030-90065-6_18] [Reference Citation Analysis]
110 Hosamirudsari H, Kheyri Z, Alizadeh M, Akbarpour S, Niya MK, Aliasgharpour F, Meidan M, Hassanzadeh S, Dowran R, Jafarpour A. Renin-Angiotensin-Aldosterone axis inhibition improves outcome of diabetic patients with chronic hypertension and COVID-19: An Iranian perspective. Adv Biomed Res 2022;11:109. [DOI: 10.4103/abr.abr_177_2] [Reference Citation Analysis]
111 Yaseen MO, Yaseen M, Khan TM, Rehman I, Suleiman AK, Baig MR, Jaber AA, Telb A, Alnafoosi FN. Pharmacotherapeutic Evaluation of Covid-19 Patients Suffering from Acute Kidney Injury. Arch Pharm Pract 2022;13:78-87. [DOI: 10.51847/n74tsc598e] [Reference Citation Analysis]
112 Qi X, Shen L, Chen J, Shi M, Shen B. Predicting the Disease Severity of Virus Infection. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-981-16-8969-7_6] [Reference Citation Analysis]
113 Impact of COVID-19 Pandemic on Population-Level Interest in Skincare: Evidence from a Google Trends. EJMHS 2021. [DOI: 10.34104/ejmhs.021.01470160] [Reference Citation Analysis]
114 Ong AN, Tan CC, Cañete MT, Lim BA, Robles J. Association Between Metformin Use and Mortality among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection. J ASEAN Fed Endocr Soc 2021;36:133-41. [PMID: 34966196 DOI: 10.15605/jafes.036.02.20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
115 Çakmak R, Telci Çaklili Ö, Ok A, Mutlu Ü, Saribeyliler G, Seferova Nasifova V, Medetalibeyoğlu A, Şenkal N, Çatma Y, Kose M. COVID-19 and Diabetes Mellitus: Are there any Differences in Outcomes with Anti-Diabetic Drugs? Turkish Journal of Diabetes and Obesity 2021;5:279-284. [DOI: 10.25048/tudod.959022] [Reference Citation Analysis]
116 Wang W, Chai Z, Cooper ME, Zimmet PZ, Guo H, Ding J, Yang F, Chen X, Lin X, Zhang K, Zhong Q, Li Z, Zhang P, Wu Z, Guan X, Zhang L, He K. High Fasting Blood Glucose Level With Unknown Prior History of Diabetes Is Associated With High Risk of Severe Adverse COVID-19 Outcome. Front Endocrinol (Lausanne) 2021;12:791476. [PMID: 34956098 DOI: 10.3389/fendo.2021.791476] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
117 Espiritu AI, Chiu HHC, Sy MCC, Anlacan VMM, Jamora RDG; Philippine CORONA Study Group. The outcomes of patients with diabetes mellitus in The Philippine CORONA Study. Sci Rep 2021;11:24436. [PMID: 34952903 DOI: 10.1038/s41598-021-03898-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
118 Singer ME, Dorrance KA, Oxenreiter MM, Yan KR, Close KL. The type 2 diabetes 'modern preventable pandemic' and replicable lessons from the COVID-19 crisis. Prev Med Rep 2022;25:101636. [PMID: 34909369 DOI: 10.1016/j.pmedr.2021.101636] [Reference Citation Analysis]
119 Al Argan R, Alkhafaji D, Al Elq A, Albaker W, Alqatari S, Alzaki A, Alwaheed A, Al Said A, Bukhari H, Al Warthan S, Zeeshan M, AlRubaish F, AlElq Z, Alsahlawi A, Alalwan M, AlHwiesh A, Alabdrabalnabi FI. The Impact of Diabetes Mellitus and Hyperglycemia on the Severity and Outcome of Patients with COVID-19 Disease: A Single-Center Experience. Int J Gen Med 2021;14:9445-57. [PMID: 34908871 DOI: 10.2147/IJGM.S338800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
120 Friedman MR, Kempf MC, Benning L, Adimora AA, Aouizerat B, Cohen MH, Hatfield Q, Merenstein D, Mimiaga MJ, Plankey MW, Sharma A, Sheth AN, Ramirez C, Stosor V, Wagner MCE, Wilson TE, D'Souza G, Weiss DJ. Prevalence of COVID-19-Related Social Disruptions and Effects on Psychosocial Health in a Mixed-Serostatus Cohort of Men and Women. J Acquir Immune Defic Syndr 2021;88:426-38. [PMID: 34757972 DOI: 10.1097/QAI.0000000000002799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
121 Patil S, Pemmasani SK, Chitturi N, Bhatnagar I, Acharya A, Subash LV. COVID-19 and Indian population: a comparative genetic analysis.. [DOI: 10.1101/2021.12.15.21267816] [Reference Citation Analysis]
122 Ivanov DO, Uspenskiy YP, Sarana AM, Fominykh YA, Sousova IV, Zakharov DV. Clinical features, treatment and rehabilitation of new coronavirus infection in patients with metabolic syndrome. Pediatr (SPb) 2021;12:5-25. [DOI: 10.17816/ped1255-25] [Reference Citation Analysis]
123 Reshad RAI, Riana SH, Chowdhury MA, Moin AT, Miah F, Sarkar B, Jewel NA. Diabetes in COVID-19 patients: challenges and possible management strategies. Egypt J Bronchol 2021;15. [DOI: 10.1186/s43168-021-00099-2] [Reference Citation Analysis]
124 Nicolau J, Ayala L, Sanchís P, Rodríguez I, Romano A, Dotres K, Pujol A, Masmiquel L. The coexistence of low albumin levels and obesity worsens clinical outcomes among subjects admitted for sars-cov-2 infection. Clin Nutr ESPEN 2021;46:434-8. [PMID: 34857231 DOI: 10.1016/j.clnesp.2021.09.722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
125 Amin A, Vartanian A, Poladian N, Voloshko A, Yegiazaryan A, Al-Kassir AL, Venketaraman V. Root Causes of Fungal Coinfections in COVID-19 Infected Patients. Infect Dis Rep 2021;13:1018-35. [PMID: 34940403 DOI: 10.3390/idr13040093] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
126 Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB. COVID-19, Hyperglycemia, and New-Onset Diabetes. Diabetes Care 2021;44:2645-55. [PMID: 34625431 DOI: 10.2337/dc21-1318] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 38.0] [Reference Citation Analysis]
127 Mason K, Hasan S, Darukhanavala A, Kutney K. COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes. Journal of Clinical & Translational Endocrinology 2021;26:100268. [DOI: 10.1016/j.jcte.2021.100268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
128 Gallwitz B. Corona-Pandemie: COVID-19 und Diabetes mellitus. Public Health Forum 2021;29:343-345. [DOI: 10.1515/pubhef-2021-0087] [Reference Citation Analysis]
129 Mayneris-Perxachs J, Russo MF, Ramos R, de Hollanda A, Arxé AA, Rottoli M, Arnoriaga-Rodríguez M, Comas-Cufí M, Bartoletti M, Verrastro O, Gudiol C, Fages E, Giménez M, Gil AG, Bernante P, Tinahones F, Carratalà J, Pagotto U, Hernández-Aguado I, Fernández-Aranda F, Meira F, Castro Guardiola A, Mingrone G, Fernández-Real JM; Obesity-T2DM Covid19 Study Group. Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain. Front Endocrinol (Lausanne) 2021;12:741248. [PMID: 34795637 DOI: 10.3389/fendo.2021.741248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Belikina DV, Malysheva ES, Petrov AV, Nekrasova TA, Nekaeva ES, Lavrova AE, Zarubina DG, Atduev KA, Magomedova DM, Strongin LG. COVID-19 in Patients with Diabetes: Clinical Course, Metabolic Status, Inflammation, and Coagulation Disorder. Sovrem Tekhnologii Med 2021;12:6-16. [PMID: 34796000 DOI: 10.17691/stm2020.12.5.01] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
131 Figueroa-Pizano MD, Campa-Mada AC, Carvajal-Millan E, Martinez-Robinson KG, Chu AR. The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review. AIMS Public Health 2021;8:720-42. [PMID: 34786431 DOI: 10.3934/publichealth.2021057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
132 Bellido V, Pérez A. COVID-19 and Diabetes. J Clin Med 2021;10:5341. [PMID: 34830623 DOI: 10.3390/jcm10225341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
133 Del Carpio B, Trang J, Vallejo M, Nimeh M, Lee J, Rafferty K, Messler J. High-dose insulin infusion in patients with COVID-19. BMJ Open Diabetes Res Care 2021;9:e002415. [PMID: 34764139 DOI: 10.1136/bmjdrc-2021-002415] [Reference Citation Analysis]
134 Harbuwono DS, Handayani DOTL, Wahyuningsih ES, Supraptowati N, Ananda, Kurniawan F, Wafa S, Kristanti M, Pantoro NI, Sinto R, Kurniawan H, Rebekka, Tahapary DL. Impact of diabetes mellitus on COVID-19 clinical symptoms and mortality: Jakarta's COVID-19 epidemiological registry. Prim Care Diabetes 2021:S1751-9918(21)00192-3. [PMID: 34857490 DOI: 10.1016/j.pcd.2021.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
135 Abo Elnaga HH, Abdelhalim HA, Abdellatif M, Bg H, Elnagdy B, Ashraf T, Elnaggar B, S. Eldin P, Ta I, Mosaad B, Ismail T, Boules R, Methuselah S, Rafaat P. Wallop of Symptoms and Co-morbidities on COVID-19 Outcome. TORMJ 2021;15:46-51. [DOI: 10.2174/1874306402115010046] [Reference Citation Analysis]
136 Faleh AlMutairi M, Tourkmani AM, Alrasheedy AA, ALHarbi TJ, Bin Rsheed AM, ALjehani M, AlRuthia Y. Cost-effectiveness of telemedicine care for patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia. Ther Adv Chronic Dis 2021;12:20406223211042542. [PMID: 34729144 DOI: 10.1177/20406223211042542] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
137 Hebbard C, Lee B, Katare R, Garikipati VNS. Diabetes, Heart Failure, and COVID-19: An Update. Front Physiol 2021;12:706185. [PMID: 34721055 DOI: 10.3389/fphys.2021.706185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
138 Al Harthi T, Anwar H, Al Lawati A, Al Shuriqi F, Al Rashdi F, Al Mahrouqi A, Al Ismaili M, Al Syiabi R, Al Azri H, Meah UH, Al Ghafri T. The Impact of Covid-19 on Diabetes Care in Muscat Governorate: A Retrospective Cohort Study in Primary Care. J Prim Care Community Health 2021;12:21501327211051930. [PMID: 34719302 DOI: 10.1177/21501327211051930] [Reference Citation Analysis]
139 Latha VA. Progression of knowledge in diabetes mellitus and covid-19. IJCBR 2021;8:163-168. [DOI: 10.18231/j.ijcbr.2021.035] [Reference Citation Analysis]
140 Rezaei N, Montazeri F, Malekpour MR, Ghanbari A, Azadnajafabad S, Mohammadi E, Rezaei N, Naderimagham S, Ghasemi E, Abbasi-Kangevari M, Ghamari SH, Nasserinejad M, Kaveh F, Norouzinejad A, Gouya MM, Raeisi A, Farzadfar F, Larijani B. COVID-19 in patients with diabetes: factors associated with worse outcomes. J Diabetes Metab Disord 2021;:1-10. [PMID: 34729367 DOI: 10.1007/s40200-021-00910-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
141 Ngiam JN, Chew NWS, Tham SM, Lim ZY, Li TYW, Cen S, Tambyah PA, Santosa A, Sia CH, Cross GB. Utility of conventional clinical risk scores in a low-risk COVID-19 cohort. BMC Infect Dis 2021;21:1094. [PMID: 34689760 DOI: 10.1186/s12879-021-06768-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
142 Attri B, Gupta Y, Tandon N. Covid-19 and Diabetes Mellitus. NMJI 2021;34:129-131. [DOI: 10.25259/nmji_429_21] [Reference Citation Analysis]
143 Purnamayanti NKD, Wicaksana AL. Digital Health Services among Patients with Diabetes during the COVID-19 Pandemic: A Scoping Review. Indian J Endocrinol Metab 2021;25:86-92. [PMID: 34660235 DOI: 10.4103/ijem.ijem_153_21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
144 Jacobs J, Johnson AK, Boshara A, Hunt B, Khouri C, Cruz J, Glick N. COVID-19 health inequities and association with mechanical ventilation and prolonged length of stay at an urban safety-net health system in Chicago. PLoS One 2021;16:e0258243. [PMID: 34644327 DOI: 10.1371/journal.pone.0258243] [Reference Citation Analysis]
145 Holland D, Heald AH, Stedman M, Hanna F, Wu P, Duff C, Green L, Robinson S, Halsall I, Gaskell N, Pemberton J, Bloor C, Fryer AA. Assessment of the effect of the COVID-19 pandemic on UK HbA1c testing: implications for diabetes management and diagnosis. J Clin Pathol 2021:jclinpath-2021-207776. [PMID: 34645702 DOI: 10.1136/jclinpath-2021-207776] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
146 Jacob E, Avery A. Energy-restricted interventions are effective for the remission of newly diagnosed type 2 diabetes: A systematic review of the evidence base. Obes Sci Pract 2021;7:606-18. [PMID: 34631138 DOI: 10.1002/osp4.504] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
147 Pettus J, Skolnik N. Importance of diabetes management during the COVID-19 pandemic. Postgrad Med 2021;133:912-9. [PMID: 34602003 DOI: 10.1080/00325481.2021.1978704] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
148 Xu Y, Yang X, Bian H, Xia M. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management. Lipids Health Dis 2021;20:126. [PMID: 34602072 DOI: 10.1186/s12944-021-01564-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
149 Buggs-Saxton C. Care of Pediatric Patients with Diabetes During the Coronavirus Disease 2019 (COVID-19) Pandemic. Pediatr Clin North Am 2021;68:1093-101. [PMID: 34538301 DOI: 10.1016/j.pcl.2021.05.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
150 De Luca G, Nardin M, Algowhary M, Uguz B, Oliveira DC, Ganyukov V, Zimbakov Z, Cercek M, Jensen LO, Loh PH, Calmac L, Roura Ferrer G, Quadros A, Milewski M, Scotto di Uccio F, von Birgelen C, Versaci F, Ten Berg J, Casella G, Lung AWS, Kala P, Díez Gil JL, Carrillo X, Dirksen M, Becerra-munoz VM, Lee MK, Juzar DA, de Moura Joaquim R, Paladino R, Milicic D, Davlouros P, Bakraceski N, Zilio F, Donazzan L, Kraaijeveld A, Galasso G, Lux A, Marinucci L, Guiducci V, Menichelli M, Scoccia A, Yamac AH, Mert KU, Flores Rios X, Kovarnik T, Kidawa M, Moreu J, Flavien V, Fabris E, Martínez-luengas IL, Boccalatte M, Bosa Ojeda F, Arellano-serrano C, Caiazzo G, Cirrincione G, Kao H, Sanchis Forés J, Vignali L, Pereira H, Manzo S, Ordoñez S, Arat Özkan A, Scheller B, Lehtola H, Teles R, Mantis C, Antti Y, Brum Silveira JA, Zoni R, Bessonov I, Savonitto S, Kochiadakis G, Alexopulos D, Uribe CE, Kanakakis J, Faurie B, Gabrielli G, Gutierrez Barrios A, Bachini JP, Rocha A, Tam FC, Rodriguez A, Lukito AA, Saint-joy V, Pessah G, Tuccillo A, Cortese G, Parodi G, Bouraghda MA, Kedhi E, Lamelas P, Suryapranata H, Verdoia M. Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic. Diabetes Epidemiology and Management 2021;4:100022. [DOI: 10.1016/j.deman.2021.100022] [Reference Citation Analysis]
151 León-Pedroza JI, Rodríguez-Cortés O, Flores-Mejía R, Gaona-Aguas CV, González-Chávez A. Impact of Metabolic Syndrome in the Clinical Outcome of Disease by SARS-COV-2. Arch Med Res 2021;52:738-45. [PMID: 33926762 DOI: 10.1016/j.arcmed.2021.04.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
152 Rhee SY. Diabetes, Obesity, and COVID-19. J Korean Diabetes 2021;22:174-178. [DOI: 10.4093/jkd.2021.22.3.174] [Reference Citation Analysis]
153 Markova TN, Lysenko MA, Ivanova AA, Pavlova ES, Ponomareva AA, Chibisova VV, Isaev TK, Sinyavkin DO, Mkrtumyan AM. Prevalence of carbohydrate metabolism disorders in patients with new coronavirus infection. Diabetes mellitus 2021;24:222-230. [DOI: 10.14341/dm12712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
154 Demeterco-Berggren C, Ebekozien O, Rompicherla S, Jacobsen L, Accacha S, Gallagher MP, Todd Alonso G, Seyoum B, Vendrame F, Haw JS, Basina M, Levy CJ, Maahs DM. Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study. J Clin Endocrinol Metab 2022;107:410-8. [PMID: 34581790 DOI: 10.1210/clinem/dgab668] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
155 Melvin WJ, Audu CO, Davis FM, Sharma SB, Joshi A, DenDekker A, Wolf S, Barrett E, Mangum K, Zhou X, Bame M, Ruan A, Obi A, Kunkel SL, Moore BB, Gallagher KA. Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2. Proc Natl Acad Sci U S A 2021;118:e2101071118. [PMID: 34479991 DOI: 10.1073/pnas.2101071118] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
156 Kazakou P, Paschou SA, Psaltopoulou T, Gavriatopoulou M, Korompoki E, Stefanaki K, Kanouta F, Kassi GN, Dimopoulos MA, Mitrakou A. Early and late endocrine complications of COVID-19. Endocr Connect 2021;10:R229-39. [PMID: 34424853 DOI: 10.1530/EC-21-0184] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
157 Klarskov CK, Windum NA, Olsen MT, Dungu AM, Jensen AK, Lindegaard B, Pedersen-Bjergaard U, Lommer Kristensen P. Telemetric continuous glucose monitoring during the COVID-19 pandemic in isolated hospitalized patients in Denmark - a randomized controlled exploratory trial. Diabetes Technol Ther 2021. [PMID: 34524009 DOI: 10.1089/dia.2021.0291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
158 Gangadharan C, Ahluwalia R, Sigamani A. Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity . World J Diabetes 2021; 12(9): 1550-1562 [PMID: 34630907 DOI: 10.4239/wjd.v12.i9.1550] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
159 Hakim A, Hasan MM, Hasan M, Lokman SM, Azim KF, Raihan T, Chowdhury PA, Azad AK. Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges. Front Microbiol 2021;12:637554. [PMID: 34512561 DOI: 10.3389/fmicb.2021.637554] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
160 Katsiki N, Gómez-Huelgas R, Mikhailidis DP, Pérez-Martínez P. Narrative review on clinical considerations for patients with diabetes and COVID-19: More questions than answers. Int J Clin Pract 2021;75:e14833. [PMID: 34510676 DOI: 10.1111/ijcp.14833] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
161 Morse J, Gay W, Korwek KM, McLean LE, Poland RE, Guy J, Sands K, Perlin JB. Hyperglycaemia increases mortality risk in non-diabetic patients with COVID-19 even more than in diabetic patients. Endocrinol Diabetes Metab 2021;4:e00291. [PMID: 34505406 DOI: 10.1002/edm2.291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
162 Xie W, Wu N, Wang B, Xu Y, Zhang Y, Xiang Y, Zhang W, Chen Z, Yuan Z, Li C, Jia X, Shan Y, Xu B, Bai L, Zhong L, Li Y. Fasting plasma glucose and glucose fluctuation are associated with COVID-19 prognosis regardless of pre-existing diabetes. Diabetes Res Clin Pract 2021;180:109041. [PMID: 34500004 DOI: 10.1016/j.diabres.2021.109041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
163 Campos-Murguía A, Román-Calleja BM, González-Regueiro JA, Hurtado-Díaz-de-León I, Solís-Ortega AA, Flores-García NC, García-Juárez I, Ruiz-Margáin A, Macías-Rodríguez RU. Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19. World J Gastroenterol 2021; 27(33): 5502-5519 [PMID: 34588748 DOI: 10.3748/wjg.v27.i33.5502] [Reference Citation Analysis]
164 Nassar M, Daoud A, Nso N, Medina L, Ghernautan V, Bhangoo H, Nyein A, Mohamed M, Alqassieh A, Soliman K, Alfishawy M, Sachmechi I, Misra A. Diabetes Mellitus and COVID-19: Review Article. Diabetes Metab Syndr 2021;15:102268. [PMID: 34562865 DOI: 10.1016/j.dsx.2021.102268] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
165 Shah VS, Pareikh D, Manjunatha BS. Salivary alpha-amylase-biomarker for monitoring type II diabetes. J Oral Maxillofac Pathol 2021;25:441-5. [PMID: 35281155 DOI: 10.4103/jomfp.jomfp_84_21] [Reference Citation Analysis]
166 Lesniak C, Ong R, Akula MS, Douedi S, Akoluk A, Soomro R, Copca-Alvarez A, Purewal T, Patel I, Upadhyaya V, Cheng J, Jain A, Asif A, Chalasani K, Hossain MA. Inpatient glycemic control and outcome of COVID-19 patients: A retrospective cohort. SAGE Open Med 2021;9:20503121211039105. [PMID: 34422272 DOI: 10.1177/20503121211039105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
167 Jayaswal SK, Singh S, Malik PS, Venigalla SK, Gupta P, Samaga SN, Hota RN, Bhatia SS, Gupta I. Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India. Diabetes Metab Syndr 2021;15:102248. [PMID: 34412000 DOI: 10.1016/j.dsx.2021.102248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
168 Mistry S, Gouripeddi R, Facelli JC, Facelli JC. Data-driven identification of temporal glucose patterns in a large cohort of nondiabetic patients with COVID-19 using time-series clustering. JAMIA Open 2021;4:ooab063. [PMID: 34409266 DOI: 10.1093/jamiaopen/ooab063] [Reference Citation Analysis]
169 Wang W, Sun Y, Wang S, Sun Y. The Relationship Between Insulin Use And Increased Mortality In Patients With COVID-19 And Diabetes: A Meta-Analysis. Endocr Res 2021;:1-7. [PMID: 34409914 DOI: 10.1080/07435800.2021.1967376] [Reference Citation Analysis]
170 Laurenzi A, Caretto A, Molinari C, Bazzigaluppi E, Brigatti C, Marzinotto I, Mercalli A, Melzi R, Nano R, Tresoldi C, Landoni G, Ciceri F, Lampasona V, Scavini M, Piemonti L. Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia. Biology (Basel) 2021;10:754. [PMID: 34439986 DOI: 10.3390/biology10080754] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
171 Danne T, Limbert C, Puig Domingo M, Del Prato S, Renard E, Choudhary P, Seibold A. Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future. Diabetes Ther 2021;12:2289-310. [PMID: 34338994 DOI: 10.1007/s13300-021-01114-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
172 Farag AA, Hassanin HM, Soliman HH, Sallam A, Sediq AM, Abd Elbaser ES, Elbanna K. Newly Diagnosed Diabetes in Patients with COVID-19: Different Types and Short-Term Outcomes. Trop Med Infect Dis 2021;6:142. [PMID: 34449740 DOI: 10.3390/tropicalmed6030142] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
173 Kinjalk N, Kinjalk T, Nandan Prasad K, Kinjalk A, Kinjalk M. NEW ONSET DIABETES MELLITUS IN SECOND WAVE OF COVID -19 PATIENTS IN NORTH INDIA. ijsr 2021. [DOI: 10.36106/ijsr/9303741] [Reference Citation Analysis]
174 Govender N, Khaliq OP, Moodley J, Naicker T. Insulin resistance in COVID-19 and diabetes. Prim Care Diabetes 2021;15:629-34. [PMID: 33849817 DOI: 10.1016/j.pcd.2021.04.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 16.0] [Reference Citation Analysis]
175 Stulin I, Montes de Oca M, Blanco G, Sánchez L, Silva I, Quevedo J, Arvelo MC, Valera N, Papa I, Bacci HCMDCCV, de Abreu F, Villarroel H, Catari JC, Lopez JL, Moran B, Cárdenas C, Santucci S, Viloria JL, Gómez J, Martinelli A, García E, Guzmán M. Caracterización clínica, según niveles de glucemia, de pacientes hospitalizados por COVID-19: serie de casos. Invest Clin 2021;62:27-42. [DOI: 10.22209/ic.v62s2a03] [Reference Citation Analysis]
176 Borgnakke WS, Poudel P. Diabetes and Oral Health: Summary of Current Scientific Evidence for Why Transdisciplinary Collaboration Is Needed. Front Dent Med 2021;2:709831. [DOI: 10.3389/fdmed.2021.709831] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
177 Stevens JS, Bogun MM, McMahon DJ, Zucker J, Kurlansky P, Mohan S, Yin MT, Nickolas TL, Pajvani UB. Diabetic ketoacidosis and mortality in COVID-19 infection. Diabetes Metab 2021;47:101267. [PMID: 34332112 DOI: 10.1016/j.diabet.2021.101267] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
178 Logette E, Lorin C, Favreau C, Oshurko E, Coggan JS, Casalegno F, Sy MF, Monney C, Bertschy M, Delattre E, Fonta PA, Krepl J, Schmidt S, Keller D, Kerrien S, Scantamburlo E, Kaufmann AK, Markram H. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19. Front Public Health 2021;9:695139. [PMID: 34395368 DOI: 10.3389/fpubh.2021.695139] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
179 Kesavadev J, Basanth A, Krishnan G, Vitale R, Parameswaran H, Shijin S, R S, Raj S, Ashik A, Shankar A, Badarudeen S, Raveendran AV, Rajalakshmy I, Sanal G, Manoj A, Jose R, Unes Y, Jothydev S. A new interventional home care model for COVID management: Virtual Covid IP. Diabetes Metab Syndr 2021;15:102228. [PMID: 34330071 DOI: 10.1016/j.dsx.2021.102228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
180 Ibrahim S, Lowe JR, Bramante CT, Shah S, Klatt NR, Sherwood N, Aronne L, Puskarich M, Tamariz L, Palacio A, Bomberg E, Usher M, King S, Benson B, Vojta D, Tignanelli C, Ingraham N. Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit. Front Endocrinol (Lausanne) 2021;12:587801. [PMID: 34367059 DOI: 10.3389/fendo.2021.587801] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
181 Shauly-Aharonov M, Shafrir A, Paltiel O, Calderon-Margalit R, Safadi R, Bicher R, Barenholz-Goultschin O, Stokar J. Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: New insights from a population-based study. PLoS One 2021;16:e0254847. [PMID: 34293038 DOI: 10.1371/journal.pone.0254847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
182 Li Z, Jiang N, Li X, Yang B, Jin M, Sun Y, He Y, Liu Y, Wang Y, Si D, Ma P, Zhang J, Liu T, Yu Q. Two novel nomograms based on inflammatory cytokines or lymphocyte subsets to differentially diagnose severe or critical and Non-Severe COVID-19. Aging (Albany NY) 2021;13:17961-77. [PMID: 34282057 DOI: 10.18632/aging.203307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
183 Lim S, Kong AP, Tuomilehto J. Influence of COVID-19 pandemic and related quarantine procedures on metabolic risk. Prim Care Diabetes 2021:S1751-9918(21)00125-X. [PMID: 34312109 DOI: 10.1016/j.pcd.2021.07.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
184 Patel AJ, Klek SP, Peragallo-Dittko V, Goldstein M, Burdge E, Nadile V, Ramadhar J, Islam S, Rothberger GD. Correlation of Hemoglobin A1C and Outcomes in Patients Hospitalized With COVID-19. Endocr Pract 2021:S1530-891X(21)01140-X. [PMID: 34284145 DOI: 10.1016/j.eprac.2021.07.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
185 Viurcos-Sanabria R, Escobedo G. Immunometabolic bases of type 2 diabetes in the severity of COVID-19. World J Diabetes 2021; 12(7): 1026-1041 [PMID: 34326952 DOI: 10.4239/wjd.v12.i7.1026] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
186 Estedlal A, Jeddi M, Heydari ST, Jahromi MG, Dabbaghmanesh MH. Impacts of diabetes mellitus on clinical and para-clinical parameters among COVID-19 patients. J Diabetes Metab Disord 2021;:1-9. [PMID: 34277497 DOI: 10.1007/s40200-021-00844-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
187 Anastasiou G, Hatziagelaki E, Liberopoulos E. Could Dapagliflozin Attenuate COVID-19 Progression in High-Risk Patients With or Without Diabetes? Behind DARE-19 Concept. J Cardiovasc Pharmacol 2021;78:e12-9. [PMID: 34001719 DOI: 10.1097/FJC.0000000000001011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
188 Sarwani A, Al Saeed M, Taha H, Al Fardan RM. New-Onset Diabetes Mellitus Presenting As Diabetic Ketoacidosis in Patients With COVID-19: A Case Series. Cureus 2021;13:e16290. [PMID: 34381649 DOI: 10.7759/cureus.16290] [Reference Citation Analysis]
189 Nouri-Keshtkar M, Taghizadeh S, Farhadi A, Ezaddoustdar A, Vesali S, Hosseini R, Totonchi M, Kouhkan A, Chen C, Zhang JS, Bellusci S, Tahamtani Y. Potential Impact of Diabetes and Obesity on Alveolar Type 2 (AT2)-Lipofibroblast (LIF) Interactions After COVID-19 Infection. Front Cell Dev Biol 2021;9:676150. [PMID: 34307358 DOI: 10.3389/fcell.2021.676150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
190 James PT, Ali Z, Armitage AE, Bonell A, Cerami C, Drakesmith H, Jobe M, Jones KS, Liew Z, Moore SE, Morales-Berstein F, Nabwera HM, Nadjm B, Pasricha SR, Scheelbeek P, Silver MJ, Teh MR, Prentice AM. The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review. J Nutr 2021;151:1854-78. [PMID: 33982105 DOI: 10.1093/jn/nxab059] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 18.0] [Reference Citation Analysis]
191 Magdy Beshbishy A, Oti VB, Hussein DE, Rehan IF, Adeyemi OS, Rivero-Perez N, Zaragoza-Bastida A, Shah MA, Abouelezz K, Hetta HF, Cruz-Martins N, Batiha GE. Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review. Front Public Health 2021;9:591982. [PMID: 34307267 DOI: 10.3389/fpubh.2021.591982] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
192 Khanh VC, Fukushige M, Chang YH, Hoang NN, Yamashita T, Obata-Yasuoka M, Hamada H, Osaka M, Hiramatsu Y, Ohneda O. Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions. Stem Cells Dev 2021;30:758-72. [PMID: 34074129 DOI: 10.1089/scd.2021.0065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
193 Gaussen A, Hornby L, Rockl G, O'Brien S, Delage G, Sapir-Pichhadze R, Drews SJ, Weiss MJ, Lewin A. Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation. Transplantation 2021;105:1405-22. [PMID: 33724248 DOI: 10.1097/TP.0000000000003744] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
194 Barmanray RD, Tsan J, Kyi M, Gorelik A, Fourlanos S. The storm that was delayed: the deterioration of an in-hospital diabetes process-of-care metric during the COVID-19 pandemic. British Journal of Healthcare Management 2021;27:166-171. [DOI: 10.12968/bjhc.2020.0139] [Reference Citation Analysis]
195 Shah H, Khan MSH, Dhurandhar NV, Hegde V. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19. Acta Diabetol 2021;58:831-43. [PMID: 33587177 DOI: 10.1007/s00592-020-01636-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
196 Sarkar S, Das D, Borsingh Wann S, Kalita J, Manna P. Is diabetes mellitus a wrongdoer to COVID-19 severity? Diabetes Res Clin Pract 2021;178:108936. [PMID: 34217771 DOI: 10.1016/j.diabres.2021.108936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
197 Meijer RI, Hoekstra T, van den Oever NCG, Simsek S, van den Bergh JP, Douma RA, Reidinga AC, Moeniralam HS, Dormans T, Smits MM; Amsterdam UMC COVID-19 biobank study group. Treatment with a DPP-4 inhibitor at time of hospital admission for COVID-19 is not associated with improved clinical outcomes: data from the COVID-PREDICT cohort study in The Netherlands. J Diabetes Metab Disord 2021;:1-6. [PMID: 34222054 DOI: 10.1007/s40200-021-00833-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
198 Ealey KN, Phillips J, Sung HK. COVID-19 and obesity: fighting two pandemics with intermittent fasting. Trends Endocrinol Metab 2021;32:706-20. [PMID: 34275726 DOI: 10.1016/j.tem.2021.06.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
199 Unnikrishnan R, Misra A. Diabetes and COVID19: a bidirectional relationship. Eur J Clin Nutr 2021;75:1332-6. [PMID: 34163019 DOI: 10.1038/s41430-021-00961-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
200 Klonoff DC, Messler J, Valk T, Jagannathan R, Pasquel FJ, Umpierrez GE. Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia. J Diabetes Sci Technol 2021;15:1181-7. [PMID: 34159841 DOI: 10.1177/19322968211013369] [Reference Citation Analysis]
201 Unnikrishnan R, Misra A. Diabetes and COVID19: a bidirectional relationship. Nutr Diabetes 2021;11:21. [PMID: 34168110 DOI: 10.1038/s41387-021-00163-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
202 Haymana C, Demirci I, Tasci I, Cakal E, Salman S, Ertugrul D, Ata N, Unluturk U, Dagdelen S, Atmaca A, Sahin M, Celik O, Demir T, Emral R, Sahin I, Caglayan M, Satman I, Sonmez A. Clinical outcomes of non-diabetic COVID-19 patients with different blood glucose levels: a nationwide Turkish study (TurCoGlycemia). Endocrine 2021;73:261-9. [PMID: 34156609 DOI: 10.1007/s12020-021-02789-9] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
203 Varghese E, Samuel SM, Liskova A, Kubatka P, Büsselberg D. Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing. PLoS Pathog 2021;17:e1009634. [PMID: 34157054 DOI: 10.1371/journal.ppat.1009634] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
204 Landstra CP, de Koning EJP. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course. Front Endocrinol (Lausanne) 2021;12:649525. [PMID: 34220706 DOI: 10.3389/fendo.2021.649525] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 23.0] [Reference Citation Analysis]
205 Chopra A, Tillu G, Chuadhary K, Reddy G, Srivastava A, Lakdawala M, Gode D, Reddy H, Tamboli S, Saluja M, Sarmukkaddam S, Gundeti M, Raut A, Rao B, Yadav B, Srikanth N, Patwardhan B. Coadministration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: A randomised, controlled, multicentric clinical trial.. [DOI: 10.1101/2021.06.12.21258345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
206 Du Y, Baumert J, Damerow S, Rommel A, Scheidt-Nave C, Heidemann C. Utilisation of outpatient medical services by people with diagnosed diabetes during the COVID-19 pandemic in Germany. J Health Monit 2021;6:51-8. [PMID: 35146310 DOI: 10.25646/8333] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
207 Aitbaev K, Mamutova S, Murkamilov I, Fomin V, Kudaibergenova I, Murkamilova Z, Yusupov F. Metformin in COVID-19 Therapy in Patients with Diabetes Mellitus: Benefit or Harm? BSP 2021;7:222-234. [DOI: 10.33619/2414-2948/67/25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
208 Martínez-Murillo C, Ramos Peñafiel C, Basurto L, Balcázar-Hernández L, Pellón K, Flores López E, Li Gómez B, Ledesma ME, Rivera Tapia R, Madera Maldonado E, Bejarano Rosales M, Barranco Lampon G, Zazueta JF. COVID-19 in a country with a very high prevalence of diabetes: The impact of admission hyperglycaemia on mortality. Endocrinol Diabetes Metab 2021;4:e00279. [PMID: 34277995 DOI: 10.1002/edm2.279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
209 Pranata R, Henrina J, Raffaello WM, Lawrensia S, Huang I. Diabetes and COVID-19: The past, the present, and the future. Metabolism 2021;121:154814. [PMID: 34119537 DOI: 10.1016/j.metabol.2021.154814] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
210 Kumar B, Mittal M, Gopalakrishnan M, Garg MK, Misra S. Effect of plasma glucose at admission on COVID-19 mortality: experience from a tertiary hospital. Endocr Connect 2021;10:589-98. [PMID: 33971617 DOI: 10.1530/EC-21-0086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
211 Rajpal A, Sayyed Kassem L, Aron DC. Management of diabetes in elderly patients during the COVID-19 pandemic: current and future perspectives. Expert Rev Endocrinol Metab 2021;16:181-9. [PMID: 34096441 DOI: 10.1080/17446651.2021.1927708] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
212 Kristan MM, Kim YK, Nelson T, Moxley MC, Yip TC, Munir K, Malek R. Predictors of Severe COVID-19 in Patients With Diabetes: A Multicenter Review. Endocr Pract 2021;27:842-9. [PMID: 34102308 DOI: 10.1016/j.eprac.2021.05.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
213 Nichols JH, Brandler ES, Fantz CR, Fisher K, Goodman MD, Headden G, Hoppensteadt D, Matika R, Peacock WF, Rodrigo J, Schützenmeister A, Swanson JR, Canada-Vilalta C, Miles G, Tran N. A Multicenter Evaluation of a Point-of-Care Blood Glucose Meter System in Critically Ill Patients. J Appl Lab Med 2021;6:820-33. [PMID: 33837390 DOI: 10.1093/jalm/jfab005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
214 Mehta PB, Kohn MA, Koliwad SK, Rushakoff RJ. Lack of association between either outpatient or inpatient glycemic control and COVID-19 illness severity or mortality in patients with diabetes. BMJ Open Diabetes Res Care 2021;9:e002203. [PMID: 34059527 DOI: 10.1136/bmjdrc-2021-002203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
215 Rosanio FM, Mozzillo E, Cimbalo C, Casertano A, Sepe A, Raia V, Franzese A, Tosco A. Diabetes outbreak during COVID19 lock-down in a prediabetic patient with cystic fibrosis long treated with glargine. Ital J Pediatr 2021;47:121. [PMID: 34078438 DOI: 10.1186/s13052-021-01076-7] [Reference Citation Analysis]
216 Büyükkaya Besen D, Dervişoğlu M. COVID-19 SALGININDA DİYABET YÖNETİMİ VE HEMŞİRENİN ROLÜ. Gazi Sağlık Bilimleri Dergisi 2021. [DOI: 10.52881/gsbdergi.887427] [Reference Citation Analysis]
217 Wei W, Sivapalasingam S, Mellis S, Geba GP, Jalbert JJ. A Retrospective Study of COVID-19-Related Urgent Medical Visits and Hospitalizations After Outpatient COVID-19 Diagnosis in the US. Adv Ther 2021;38:3185-202. [PMID: 33961213 DOI: 10.1007/s12325-021-01742-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
218 Muñoz CE, Chao LC. Impact of COVID-19 on Youth With Type 2 Diabetes: Lessons Learned From a Pediatric Endocrinologist and a Psychologist. Front Endocrinol (Lausanne) 2021;12:650492. [PMID: 34122332 DOI: 10.3389/fendo.2021.650492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
219 Hamouri S, Samrah SM, Albawaih O, Saleh Z, Smadi MM, Alhazymeh A, Syaj S. Pulmonary Barotrauma in COVID-19 Patients: Invasive versus Noninvasive Positive Pressure Ventilation. Int J Gen Med 2021;14:2017-32. [PMID: 34079341 DOI: 10.2147/IJGM.S314155] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
220 Prattichizzo F, de Candia P, Nicolucci A, Ceriello A. Elevated HbA1c levels in pre-Covid-19 infection increases the risk of mortality: A sistematic review and meta-analysis. Diabetes Metab Res Rev 2021;:e3476. [PMID: 34018307 DOI: 10.1002/dmrr.3476] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
221 Gallwitz B, Rathmann W. COVID-19 und Diabetes: Folgen der Pandemie. Deutsches Ärzteblatt Online 2021. [DOI: 10.3238/persdia.2021.05.17.02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
222 Kountouri A, Korakas E, Ikonomidis I, Raptis A, Tentolouris N, Dimitriadis G, Lambadiari V. Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes. Antioxidants (Basel) 2021;10:752. [PMID: 34065123 DOI: 10.3390/antiox10050752] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
223 Logette E, Lorin C, Favreau C, Oshurko E, Coggan JS, Casalegno F, Sy MF, Monney C, Bertschy M, Delattre E, Fonta P, Krepl J, Schmidt S, Keller D, Kerrien S, Scantamburlo E, Kaufmann A, Markram H. Elevated Blood Glucose Levels as a Primary Risk Factor for the Severity of COVID-19.. [DOI: 10.1101/2021.04.29.21256294] [Reference Citation Analysis]
224 Alonso N, Batule S. Diabetes mellitus and SARS-CoV-2 infection. Clínica e Investigación en Arteriosclerosis (English Edition) 2021;33:148-150. [DOI: 10.1016/j.artere.2021.06.003] [Reference Citation Analysis]
225 D'Arcy R, Courtney CH. Diabetes and Covid-19: Clinical implications and novel management strategies. Ulster Med J 2021;90:81-5. [PMID: 34276085] [Reference Citation Analysis]
226 Alonso N, Batule S. COVID-19 y diabetes mellitus. Importancia del control glucémico. Clínica e Investigación en Arteriosclerosis 2021;33:148-150. [DOI: 10.1016/j.arteri.2021.05.001] [Reference Citation Analysis]
227 Jin S, Hu W. Severity of COVID-19 and Treatment Strategy for Patient With Diabetes. Front Endocrinol (Lausanne) 2021;12:602735. [PMID: 33995267 DOI: 10.3389/fendo.2021.602735] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
228 Rawshani A, Kjölhede EA, Rawshani A, Sattar N, Eeg-Olofsson K, Adiels M, Ludvigsson J, Lindh M, Gisslén M, Hagberg E, Lappas G, Eliasson B, Rosengren A. Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study. Lancet Reg Health Eur 2021;4:100105. [PMID: 33969336 DOI: 10.1016/j.lanepe.2021.100105] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 15.5] [Reference Citation Analysis]
229 Laurenzi A, Caretto A, Molinari C, Bazzigaluppi E, Brigatti C, Marzinotto I, Mercalli A, Melzi R, Nano R, Tresoldi C, Landoni G, Ciceri F, Lampasona V, Scavini M, Piemonti L. Preexisting diabetes and COVID-associated hyperglycaemia in patients with COVID-19 pneumonia.. [DOI: 10.1101/2021.04.17.21255548] [Reference Citation Analysis]
230 Sarigumba M, Aragon J, Kanapi MP. Baseline Glycemic Status and Outcome of Persons with Type 2 Diabetes with COVID-19 Infections: A Single-Center Retrospective Study. J ASEAN Fed Endocr Soc 2021;36:45-9. [PMID: 34177087 DOI: 10.15605/jafes.036.01.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
231 Ceriello A, Prattichizzo F. Pharmacological management of COVID-19 in type 2 diabetes. J Diabetes Complications 2021;35:107927. [PMID: 33896714 DOI: 10.1016/j.jdiacomp.2021.107927] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
232 Ruslan A, Williams DM, Purnell O, Edwards R, Peter R, Stephens JW, Chudleigh R. A physician's approach and experience of managing patients with diabetes during COVID ‐19. Pract Diab 2021;38:23. [DOI: 10.1002/pdi.2329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
233 Buicu AL, Cernea S, Benedek I, Buicu CF, Benedek T. Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity. J Clin Med 2021;10:1545. [PMID: 33916917 DOI: 10.3390/jcm10081545] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
234 Ricchio M, Tassone B, Pelle MC, Mazzitelli M, Serapide F, Fusco P, Lionello R, Cancelliere A, Procopio G, Lio E, Trecarichi EM, Torti C, Irace C. Characteristics, Management, and Outcomes of Elderly Patients with Diabetes in a Covid-19 Unit: Lessons Learned from a Pilot Study. Medicina (Kaunas) 2021;57:341. [PMID: 33916210 DOI: 10.3390/medicina57040341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
235 Lazzeri C, Bonizzoli M, Batacchi S, Di Valvasone S, Chiostri M, Peris A. The prognostic role of hyperglycemia and glucose variability in covid-related acute respiratory distress Syndrome. Diabetes Res Clin Pract 2021;175:108789. [PMID: 33812902 DOI: 10.1016/j.diabres.2021.108789] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
236 Davis GM, Faulds E, Walker T, Vigliotti D, Rabinovich M, Hester J, Peng L, McLean B, Hannon P, Poindexter N, Saunders P, Perez-Guzman C, Tekwani SS, Martin GS, Umpierrez G, Agarwal S, Dungan K, Pasquel FJ. Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept. Diabetes Care 2021;44:1055-8. [PMID: 33563655 DOI: 10.2337/dc20-2085] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 16.5] [Reference Citation Analysis]
237 Saha S, Al-Rifai RH, Saha S. Diabetes prevalence and mortality in COVID-19 patients: a systematic review, meta-analysis, and meta-regression. J Diabetes Metab Disord 2021;:1-12. [PMID: 33821206 DOI: 10.1007/s40200-021-00779-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
238 Song S, Zhang S, Wang Z, Wang S, Ma Y, Ma P, Luo H, Wang M, Jin Y. Association Between Longitudinal Change in Abnormal Fasting Blood Glucose Levels and Outcome of COVID-19 Patients Without Previous Diagnosis of Diabetes. Front Endocrinol (Lausanne) 2021;12:640529. [PMID: 33859617 DOI: 10.3389/fendo.2021.640529] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
239 Mamtani M, Athavale AM, Abraham M, Vernik J, Amarah AR, Ruiz JP, Joshi AJ, Itteera M, Zhukovski SD, Madaiah RP, White BC, Hart P, Kulkarni H. Association of hyperglycaemia with hospital mortality in nondiabetic COVID-19 patients: A cohort study. Diabetes Metab 2021;47:101254. [PMID: 33781926 DOI: 10.1016/j.diabet.2021.101254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
240 Gazzaz ZJ. Diabetes and COVID-19. Open Life Sci 2021;16:297-302. [PMID: 33817321 DOI: 10.1515/biol-2021-0034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
241 Wang J, Meng W. COVID-19 and diabetes: the contributions of hyperglycemia. J Mol Cell Biol 2020;12:958-62. [PMID: 33002109 DOI: 10.1093/jmcb/mjaa054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
242 Adams JA, Lopez JR, Banderas V, Sackner MA. A single arm trial using passive simulated jogging for blunting acute hyperglycemia. Sci Rep 2021;11:6437. [PMID: 33742027 DOI: 10.1038/s41598-021-85579-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
243 Zhang W, Li C, Xu Y, He B, Hu M, Cao G, Li L, Wu S, Wang X, Zhang C, Zhao J, Xie J, Xu Z, Li Q, Wang G. Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019. Mediators Inflamm 2021;2021:8812304. [PMID: 33814982 DOI: 10.1155/2021/8812304] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
244 Satman I, Demirci I, Haymana C, Tasci I, Salman S, Ata N, Dagdelen S, Sahin I, Emral R, Cakal E, Atmaca A, Sahin M, Celik O, Demir T, Ertugrul D, Unluturk U, Arga KY, Caglayan M, Sonmez A. Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul. Diabetes Res Clin Pract 2021;174:108753. [PMID: 33741352 DOI: 10.1016/j.diabres.2021.108753] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
245 Sinclair A, Bellary S, Dhatariya KK. Diabetes in older adults - time to include frailty as a care indicator. Diabet Med 2021;38:e14560. [PMID: 33724524 DOI: 10.1111/dme.14560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
246 Ahmed FW, Kirresh OZ, Robinson AV, Majeed MS, Rouse D, Banatwalla R, Parthasarathy S, Sargent C, Castledine C, Chakera AJ. A Retrospective Study Assessing the Effect of Diabetes on Mortality in Patients With COVID-19 at a Teaching Hospital in the United Kingdom. Cureus 2021;13:e13902. [PMID: 33880258 DOI: 10.7759/cureus.13902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
247 Chowdhury TA. Diabetes and COVID-19: Diseases of racial, social and glucose intolerance. World J Diabetes 2021; 12(3): 198-205 [PMID: 33758642 DOI: 10.4239/wjd.v12.i3.198] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
248 Abdelhafiz AH, Emmerton D, Sinclair AJ. Diabetes in COVID-19 pandemic-prevalence, patient characteristics and adverse outcomes. Int J Clin Pract 2021;75:e14112. [PMID: 33630378 DOI: 10.1111/ijcp.14112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
249 Samuel SM, Varghese E, Büsselberg D. Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role. Trends Microbiol 2021:S0966-842X(21)00063-9. [PMID: 33785249 DOI: 10.1016/j.tim.2021.03.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 36] [Article Influence: 13.5] [Reference Citation Analysis]
250 Lu S, Xing Z, Zhao S, Meng X, Yang J, Ding W, Wang J, Huang C, Xu J, Chang B, Shen J. Different Appearance of Chest CT Images of T2DM and NDM Patients with COVID-19 Pneumonia Based on an Artificial Intelligent Quantitative Method. Int J Endocrinol 2021;2021:6616069. [PMID: 33790965 DOI: 10.1155/2021/6616069] [Reference Citation Analysis]
251 Garg S, Norman GJ. Impact of COVID-19 on Health Economics and Technology of Diabetes Care: Use Cases of Real-Time Continuous Glucose Monitoring to Transform Health Care During a Global Pandemic. Diabetes Technol Ther 2021;23:S15-20. [PMID: 33449822 DOI: 10.1089/dia.2020.0656] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
252 van der Linden J, Welsh JB, Hirsch IB, Garg SK. Real-Time Continuous Glucose Monitoring During the Coronavirus Disease 2019 Pandemic and Its Impact on Time in Range. Diabetes Technol Ther 2021;23:S1-7. [PMID: 33470892 DOI: 10.1089/dia.2020.0649] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
253 Lohia P, Kapur S, Benjaram S, Mir T. Association between antecedent statin use and severe disease outcomes in COVID-19: A retrospective study with propensity score matching. J Clin Lipidol 2021;15:451-9. [PMID: 33726984 DOI: 10.1016/j.jacl.2021.03.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
254 Berlie HD, Kale-Pradhan PB, Orzechowski T, Jaber LA. Mechanisms and Potential Roles of Glucose-Lowering Agents in COVID-19: A Review. Ann Pharmacother 2021;55:1386-96. [PMID: 33657863 DOI: 10.1177/1060028021999473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
255 Leong A, Cole JB, Brenner LN, Meigs JB, Florez JC, Mercader JM. Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis. PLoS Med 2021;18:e1003553. [PMID: 33661905 DOI: 10.1371/journal.pmed.1003553] [Cited by in Crossref: 46] [Cited by in F6Publishing: 61] [Article Influence: 23.0] [Reference Citation Analysis]
256 Abdel-Moneim A, Hosni A. Insights into the possible impact of COVID-19 on the endocrine system. Arch Physiol Biochem 2021;:1-9. [PMID: 33653188 DOI: 10.1080/13813455.2021.1890131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
257 Drucker DJ. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning. Cell Metab 2021;33:479-98. [PMID: 33529600 DOI: 10.1016/j.cmet.2021.01.016] [Cited by in Crossref: 126] [Cited by in F6Publishing: 122] [Article Influence: 63.0] [Reference Citation Analysis]
258 Suri JS, Agarwal S, Gupta SK, Puvvula A, Biswas M, Saba L, Bit A, Tandel GS, Agarwal M, Patrick A, Faa G, Singh IM, Oberleitner R, Turk M, Chadha PS, Johri AM, Miguel Sanches J, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Ahluwalia P, Teji J, Al-Maini M, Dhanjil SK, Sockalingam M, Saxena A, Nicolaides A, Sharma A, Rathore V, Ajuluchukwu JNA, Fatemi M, Alizad A, Viswanathan V, Krishnan PK, Naidu S. A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence. Comput Biol Med 2021;130:104210. [PMID: 33550068 DOI: 10.1016/j.compbiomed.2021.104210] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]
259 Wang W, Shen M, Tao Y, Fairley CK, Zhong Q, Li Z, Chen H, Ong JJ, Zhang D, Zhang K, Xing N, Guo H, Qin E, Guan X, Yang F, Zhang S, Zhang L, He K. Elevated glucose level leads to rapid COVID-19 progression and high fatality. BMC Pulm Med 2021;21:64. [PMID: 33627118 DOI: 10.1186/s12890-021-01413-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
260 Demidova TY, Lobanova KG, Perekhodov SN, Antsiferov MB, Oynotkinova OS. Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes. Cardiovasc Ther Prev 2021;20:2750. [DOI: 10.15829/1728-8800-2021-2750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
261 Yang Y, Cai Z, Zhang J. Hyperglycemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: a meta-analysis. Biosci Rep 2021;41:BSR20203584. [PMID: 33480978 DOI: 10.1042/BSR20203584] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
262 Shestakova MV, Kononenko IV, Kalmykova ZA, Zheleznyakova AV, Mokrysheva NG. High level of glycated hemoglobin (HbA<sub>1c</sub>) in patients with COVID-19 is a marker of the severity of the infection but not an indicator of previous diabetes mellitus. Diabetes mellitus 2021;23:504-513. [DOI: 10.14341/dm12702] [Reference Citation Analysis]
263 Lockhart SM, Griffiths H, Petrisor B, Usman A, Calvo-Latorre J, Heales L, Bansiya V, Mahroof R, Conway Morris A. The excess insulin requirement in severe COVID-19 compared to non-COVID-19 viral pneumonitis is related to the severity of respiratory failure and pre-existing diabetes. Endocrinol Diabetes Metab 2021;4:e00228. [PMID: 34268452 DOI: 10.1002/edm2.228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
264 Cariou B, Pichelin M, Goronflot T, Gonfroy C, Marre M, Raffaitin-Cardin C, Thivolet C, Wargny M, Hadjadj S, Gourdy P; CORONADO investigators. Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study. Diabetes Res Clin Pract 2021;175:108695. [PMID: 33577905 DOI: 10.1016/j.diabres.2021.108695] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
265 Gómez AM, Henao DC, Muñoz OM, Aschner P, Yepes CA, Jojoa R, Kerguelen A, Parra D, Jaramillo P, Umpierrez GE. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19. Diabetes Metab Syndr 2021;15:499-503. [PMID: 33662836 DOI: 10.1016/j.dsx.2021.02.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
266 Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, Gan H, Sun YL, Fu W, Li W, Liang HL, Cao YY, Yan Q, Cao C, Gao HY, Brüggen MC, van de Veen W, Sokolowska M, Akdis M, Akdis CA. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy 2021;76:428-55. [PMID: 33185910 DOI: 10.1111/all.14657] [Cited by in Crossref: 385] [Cited by in F6Publishing: 443] [Article Influence: 192.5] [Reference Citation Analysis]
267 Boeder S, Kulasa K. Hospital care: improving outcomes in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2021;28:14-20. [PMID: 33315629 DOI: 10.1097/MED.0000000000000601] [Reference Citation Analysis]
268 Klonoff DC, Messler JC, Umpierrez GE, Peng L, Booth R, Crowe J, Garrett V, McFarland R, Pasquel FJ. Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis. Diabetes Care 2021;44:578-85. [PMID: 33323475 DOI: 10.2337/dc20-1857] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 20.0] [Reference Citation Analysis]
269 Faulds ER, Jones L, McNett M, Smetana KS, May CC, Sumner L, Buschur E, Exline M, Ringel MD, Dungan K. Facilitators and Barriers to Nursing Implementation of Continuous Glucose Monitoring (CGM) in Critically Ill Patients With COVID-19. Endocr Pract 2021;27:354-61. [PMID: 33515756 DOI: 10.1016/j.eprac.2021.01.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
270 Pasquel FJ, Lansang MC, Dhatariya K, Umpierrez GE. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol 2021;9:174-88. [PMID: 33515493 DOI: 10.1016/S2213-8587(20)30381-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 25.5] [Reference Citation Analysis]
271 Myers AK, Kim TS, Zhu X, Liu Y, Qiu M, Pekmezaris R. Predictors of mortality in a multiracial urban cohort of persons with type 2 diabetes and novel coronavirus 19. J Diabetes 2021. [PMID: 33486896 DOI: 10.1111/1753-0407.13158] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
272 Bhatti R, Adhami S, Khamis A, Matfin G. Acute hyperglycaemia after COVID-19 vaccination in patients with stable diabetes: A Case Series (Preprint).. [DOI: 10.2196/preprints.27401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
273 Jiang N, Li Z, Yang B, Jin M, Sun Y, He Y, Liu Y, Wang Y, Si D, Ma P, Zhang J, Liu T, Yu Q. Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients. Biomed Res Int 2021;2021:9101082. [PMID: 33542929 DOI: 10.1155/2021/9101082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
274 Zhang JY, Shang T, Ahn D, Chen K, Coté G, Espinoza J, Mendez CE, Spanakis EK, Thompson B, Wallia A, Wisk LE, Kerr D, Klonoff DC. How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit. J Diabetes Sci Technol 2021;15:478-514. [PMID: 33476193 DOI: 10.1177/1932296820978399] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
275 Kandil H, Ibrahim AE, Afifi N, Arafa A. Diabetes and Risk of COVID-19 Mortality: A Systematic Review and Meta-Analysis. Infect Dis Clin Pract (Baltim Md) 2021;29:e195-7. [PMID: 34191909 DOI: 10.1097/IPC.0000000000000992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
276 Ilias I, Diamantopoulos A, Pratikaki M, Botoula E, Jahaj E, Athanasiou N, Tsipilis S, Zacharis A, Vassiliou AG, Vassiliadi DA, Kotanidou A, Tsagarakis S, Dimopoulou I. Glycemia, Beta-Cell Function and Sensitivity to Insulin in Mildly to Critically Ill Covid-19 Patients. Medicina (Kaunas). 2021;57. [PMID: 33466617 DOI: 10.3390/medicina57010068] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
277 Chow KW, Kelly DJ, Rieff MC, Skala PA, Kravets I, Charitou MM, Morley EJ, Gupta R, Miller JD. Outcomes and Healthcare Provider Perceptions of Real-Time Continuous Glucose Monitoring (rtCGM) in Patients With Diabetes and COVID-19 Admitted to the ICU. J Diabetes Sci Technol 2021;15:607-14. [PMID: 33435706 DOI: 10.1177/1932296820985263] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
278 Catic T, Jusufovic R, Tabakovic V, Hajdarevic B. Diabetology Care During COVID-19 Lockdown in Bosnia and Herzegovina - Diabetologists and Patients Perspective. Mater Sociomed 2020;32:183-6. [PMID: 33424446 DOI: 10.5455/msm.2020.32.183-186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
279 Belančić A, Kresović A, Troskot Dijan M. Glucagon-like peptide-1 receptor agonists in the era of COVID-19: Friend or foe? Clin Obes 2021;11:e12439. [PMID: 33423388 DOI: 10.1111/cob.12439] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
280 Saxena S, Kumar S, Hajare SN, Gupta S, Gautam S, Ghosh SK. 'BhAVI-23'-A spice-herb based dietary infusion possessing in-vitro anti-viral potential. J Ayurveda Integr Med 2021;12:312-9. [PMID: 33413968 DOI: 10.1016/j.jaim.2020.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
281 Mohamed F, Raal FJ, University of Witwatersrand, Johannesburg. “A new threat from an old enemy” – COVID-19 and new-onset diabetes mellitus. WJCM 2021;3:197. [DOI: 10.18772/26180197.2021.v3n3a7] [Reference Citation Analysis]
282 Fox T, Ruddiman K, Lo KB, Peterson E, DeJoy R 3rd, Salacup G, Pelayo J, Bhargav R, Gul F, Albano J, Azmaiparashvili Z, Anastasopoulou C, Patarroyo-Aponte G. The relationship between diabetes and clinical outcomes in COVID-19: a single-center retrospective analysis. Acta Diabetol 2021;58:33-8. [PMID: 32804317 DOI: 10.1007/s00592-020-01592-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
283 Hui Y, Li Y, Tong X, Wang Z, Mao X, Huang L, Zhang D. The risk factors for mortality of diabetic patients with severe COVID-19: A retrospective study of 167 severe COVID-19 cases in Wuhan. PLoS One 2020;15:e0243602. [PMID: 33382747 DOI: 10.1371/journal.pone.0243602] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
284 Shrestha E, Charkviani M, Musurakis C, Kansakar AR, Devkota A, Banjade R, Pudasainee P, Chitrakar S, Sharma A, Sous M, Padhamanbhan S, Friedman HJ, Nava GR. Type 2 diabetes is associated with increased risk of critical respiratory illness in patients COVID-19 in a community hospital. Obes Med 2021;22:100316. [PMID: 33392411 DOI: 10.1016/j.obmed.2020.100316] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
285 Sun Y, Guan X, Jia L, Xing N, Cheng L, Liu B, Zhang S, He K. Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID-19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital. J Clin Hypertens (Greenwich) 2021;23:218-31. [PMID: 33369066 DOI: 10.1111/jch.14146] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
286 Eskandarani RM, Sawan S. Diabetic Ketoacidosis on Hospitalization with COVID-19 in a Previously Nondiabetic Patient: A Review of Pathophysiology. Clin Med Insights Endocrinol Diabetes 2020;13:1179551420984125. [PMID: 33488135 DOI: 10.1177/1179551420984125] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
287 Bartolomucci A, Sapolsky RM. Psychosocial Risk Factors, Noncommunicable Diseases, and Animal Models for COVID-19. Biol Psychiatry 2021;89:e67-71. [PMID: 33487440 DOI: 10.1016/j.biopsych.2020.12.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
288 Rudroff T, Fietsam AC, Deters JR, Bryant AD, Kamholz J. Post-COVID-19 Fatigue: Potential Contributing Factors. Brain Sci 2020;10:E1012. [PMID: 33352638 DOI: 10.3390/brainsci10121012] [Cited by in Crossref: 70] [Cited by in F6Publishing: 78] [Article Influence: 23.3] [Reference Citation Analysis]
289 Saand AR, Flores M, Kewan T, Alqaisi S, Alwakeel M, Griffiths L, Wang X, Han X, Burton R, Al-Jaghbeer MJ, Abi Fadel F. Does inpatient hyperglycemia predict a worse outcome in COVID-19 intensive care unit patients? J Diabetes 2021;13:253-60. [PMID: 33216443 DOI: 10.1111/1753-0407.13137] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
290 Mithal A, Jevalikar G, Sharma R, Singh A, Farooqui KJ, Mahendru S, Krishnamurthy A, Dewan A, Budhiraja S. High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes. Diabetes Metab Syndr 2021;15:169-75. [PMID: 33360081 DOI: 10.1016/j.dsx.2020.12.029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
291 Gasmi A, Peana M, Pivina L, Srinath S, Gasmi Benahmed A, Semenova Y, Menzel A, Dadar M, Bjørklund G. Interrelations between COVID-19 and other disorders. Clin Immunol 2021;224:108651. [PMID: 33333255 DOI: 10.1016/j.clim.2020.108651] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 15.3] [Reference Citation Analysis]
292 Jiang N, Chen Z, Liu L, Yin X, Yang H, Tan X, Wang J, Li H, Tian M, Lu Z, Xiong N, Gong Y. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study. Diabetes Res Clin Pract 2021;173:108619. [PMID: 33310173 DOI: 10.1016/j.diabres.2020.108619] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
293 Giorgino F, Bhana S, Czupryniak L, Dagdelen S, Galstyan GR, Janež A, Lalić N, Nouri N, Rahelić D, Stoian AP, Raz I. Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa. Diabetes Res Clin Pract 2021;172:108617. [PMID: 33310175 DOI: 10.1016/j.diabres.2020.108617] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
294 Alsufyani HA, Alrefaie Z. Renin-Angiotensin System Implications to COVID-19 Comorbidities. J Microsc Ultrastruct 2020;8:148-51. [PMID: 33623738 DOI: 10.4103/jmau.jmau_105_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
295 Barone MTU, Ngongo B, Harnik SB, Oliveira LX, Végh D, de Luca PV, Pedrosa HC, Giraudo F, Cardona-Hernandez R, Chaudhury N, Menna-Barreto L. COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis. Diabetes Res Clin Pract 2021;171:108587. [PMID: 33307134 DOI: 10.1016/j.diabres.2020.108587] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
296 Bhatti R, Khamis AH, Khatib S, Shiraz S, Matfin G. Clinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID-19 Treatment in Dubai: Single-Centre Cross-Sectional Study. JMIR Public Health Surveill 2020;6:e22471. [PMID: 33284130 DOI: 10.2196/22471] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
297 Seiglie J, Platt J, Cromer SJ, Bunda B, Foulkes AS, Bassett IV, Hsu J, Meigs JB, Leong A, Putman MS, Triant VA, Wexler DJ, Manne-Goehler J. Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19. Diabetes Care 2020;43:2938-44. [PMID: 32847827 DOI: 10.2337/dc20-1506] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 21.7] [Reference Citation Analysis]
298 Rosen HR, O'Connell C, Nadim MK, DeClerck B, Sheibani S, DePasquale E, Sanossian N, Blodget E, Angell T. Extrapulmonary manifestations of severe acute respiratory syndrome coronavirus-2 infection. J Med Virol 2021;93:2645-53. [PMID: 33090515 DOI: 10.1002/jmv.26595] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
299 Nigro E, Perrotta F, Polito R, D'Agnano V, Scialò F, Bianco A, Daniele A. Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways. Int J Endocrinol 2020;2020:8896536. [PMID: 33312199 DOI: 10.1155/2020/8896536] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
300 Krishnamoorthy G, Arsene C, Jena N, Mogulla SM, Coakley R, Khine J, Khosrodad N, Klein A, Sule AA. Racial disparities in COVID-19 hospitalizations do not lead to disparities in outcomes. Public Health 2021;190:93-8. [PMID: 33385640 DOI: 10.1016/j.puhe.2020.11.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
301 Woolcott OO, Castilla-bancayán JP. Diabetes and Mortality Among 1.6 Million Adult Patients Screened for SARS-CoV-2 in Mexico.. [DOI: 10.1101/2020.11.25.20238345] [Reference Citation Analysis]
302 Cardona-Hernandez R, Cherubini V, Iafusco D, Schiaffini R, Luo X, Maahs DM. Children and youth with diabetes are not at increased risk for hospitalization due to COVID-19. Pediatr Diabetes 2021;22:202-6. [PMID: 33205546 DOI: 10.1111/pedi.13158] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
303 Wallia A, Prince G, Touma E, El Muayed M, Seley JJ. Caring for Hospitalized Patients with Diabetes Mellitus, Hyperglycemia, and COVID-19: Bridging the Remaining Knowledge Gaps. Curr Diab Rep 2020;20:77. [PMID: 33244614 DOI: 10.1007/s11892-020-01366-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
304 Yu B, Li C, Sun Y, Wang DW. Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes.Cell Metab. 2021;33:65-77.e2. [PMID: 33248471 DOI: 10.1016/j.cmet.2020.11.014] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 22.7] [Reference Citation Analysis]
305 Valk T, McMorrow C. Managing hyperglycemia during the COVID-19 pandemic: Improving outcomes using new technologies in intensive care.SAGE Open Med. 2020;8:2050312120974174. [PMID: 33282306 DOI: 10.1177/2050312120974174] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
306 McDonnell EP, Altomare NJ, Parekh YH, Gowda RC, Parikh PD, Lazar MH, Blaser MJ. COVID-19 as a Trigger of Recurrent Guillain-Barré Syndrome. Pathogens 2020;9:E965. [PMID: 33228253 DOI: 10.3390/pathogens9110965] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
307 Symum H, Islam MF, Hiya HK, Ali Sagor KM. Assessment of the Impact of COVID-19 pandemic on population level interest in Skincare: Evidence from a google trends-based Infodemiology study.. [DOI: 10.1101/2020.11.16.20232868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
308 Boddu SK, Aurangabadkar G, Kuchay MS. New onset diabetes, type 1 diabetes and COVID-19.Diabetes Metab Syndr. 2020;14:2211-2217. [PMID: 33395782 DOI: 10.1016/j.dsx.2020.11.012] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 22.3] [Reference Citation Analysis]
309 Pérez-Belmonte LM, Torres-Peña JD, López-Carmona MD, Ayala-Gutiérrez MM, Fuentes-Jiménez F, Huerta LJ, Muñoz JA, Rubio-Rivas M, Madrazo M, Garcia MG, Montes BV, Sola JF, Ena J, Ferrer RG, Pérez CM, Ripper CJ, Lecumberri JJN, Acedo IEA, Canteli SP, Cosío SF, Martínez FA, Rodríguez BC, Pérez-Martínez P, Ramos-Rincón JM, Gómez-Huelgas R; SEMI-COVID-19 Network. Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study. BMC Med 2020;18:359. [PMID: 33190637 DOI: 10.1186/s12916-020-01832-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 18.7] [Reference Citation Analysis]
310 Carrasco-Sánchez FJ, López-Carmona MD, Martínez-Marcos FJ, Pérez-Belmonte LM, Hidalgo-Jiménez A, Buonaiuto V, Suárez Fernández C, Freire Castro SJ, Luordo D, Pesqueira Fontan PM, Blázquez Encinar JC, Magallanes Gamboa JO, de la Peña Fernández A, Torres Peña JD, Fernández Solà J, Napal Lecumberri JJ, Amorós Martínez F, Guisado Espartero ME, Jorge Ripper C, Gómez Méndez R, Vicente López N, Román Bernal B, Rojano Rivero MG, Ramos Rincón JM, Gómez Huelgas R; SEMI-COVID-19 Network. Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry. Ann Med 2021;53:103-16. [PMID: 33063540 DOI: 10.1080/07853890.2020.1836566] [Cited by in Crossref: 64] [Cited by in F6Publishing: 45] [Article Influence: 21.3] [Reference Citation Analysis]
311 Tee LY, Alhamid SM, Tan JL, Oo TD, Chien J, Galinato P, Tan SY, Humaira S, Fong RKC, Puar TH, Loh WJ, Santosa A, Khoo J, Rosario BH. COVID-19 and Undiagnosed Pre-diabetes or Diabetes Mellitus Among International Migrant Workers in Singapore. Front Public Health 2020;8:584249. [PMID: 33262970 DOI: 10.3389/fpubh.2020.584249] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
312 Leon-Abarca JA, Memon RS, Rehan B, Iftikhar M, Chatterjee A. The impact of COVID-19 in diabetic kidney disease and chronic kidney disease: A population-based study. Acta Biomed 2020;91:e2020161. [PMID: 33525210 DOI: 10.23750/abm.v91i4.10380] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
313 Yang P, Wang N, Wang J, Luo A, Gao F, Tu Y. Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19. J Med Virol 2021;93:2168-76. [PMID: 33073361 DOI: 10.1002/jmv.26608] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
314 Cho Y, Yoon KH. Being caught in the perfect storm of a diabetes epidemic and the COVID-19 pandemic: What should we do for our patients? J Diabetes Investig 2021;12:297-300. [PMID: 33007156 DOI: 10.1111/jdi.13425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
315 Sathish T, de Mello GT, Cao Y. Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity? J Diabetes 2021;13:177-8. [PMID: 33107708 DOI: 10.1111/1753-0407.13125] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
316 Sarvazad H, Cahngaripour SH, Eskandari Roozbahani N, Izadi B. Evaluation of electrolyte status of sodium, potassium and magnesium, and fasting blood sugar at the initial admission of individuals with COVID-19 without underlying disease in Golestan Hospital, Kermanshah. New Microbes New Infect 2020;38:100807. [PMID: 33294198 DOI: 10.1016/j.nmni.2020.100807] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
317 Müller-Wieland D, Marx N, Dreher M, Fritzen K, Schnell O. COVID-19 and Cardiovascular Comorbidities. Exp Clin Endocrinol Diabetes 2020. [PMID: 33157558 DOI: 10.1055/a-1269-1405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
318 Mehta PB, Rushakoff RJ. A Diabetes and COVID-19 Dilemma: Balancing Parents’ Health & Children’s Education. J Diabetes Sci Technol 2020;14:1129-1130. [DOI: 10.1177/1932296820950287] [Reference Citation Analysis]
319 Khalili S, Moradi O, Kharazmi AB, Raoufi M, Sistanizad M, Shariat M. Comparison of Mortality Rate and Severity of Pulmonary Involvement in Coronavirus Disease-2019 Adult Patients With and Without Type 2 Diabetes: A Cohort Study. Can J Diabetes 2021;45:524-30. [PMID: 33339741 DOI: 10.1016/j.jcjd.2020.10.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
320 Gallwitz B. COVID-19 und Diabetes: Gefährliche Interaktionen. Deutsches Ärzteblatt Online 2020. [DOI: 10.3238/persdia.2020.10.30.01] [Reference Citation Analysis]
321 Palaiodimos L, Chamorro-Pareja N, Karamanis D, Li W, Zavras PD, Chang KM, Mathias P, Kokkinidis DG. Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients. Hormones (Athens) 2021;20:305-14. [PMID: 33123973 DOI: 10.1007/s42000-020-00246-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 33] [Article Influence: 8.7] [Reference Citation Analysis]
322 Mechanick JI, Rosenson RS, Pinney SP, Mancini DM, Narula J, Fuster V. Coronavirus and Cardiometabolic Syndrome: JACC Focus Seminar. J Am Coll Cardiol 2020;76:2024-35. [PMID: 33092738 DOI: 10.1016/j.jacc.2020.07.069] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
323 Futatsugi H, Iwabu M, Okada-Iwabu M, Okamoto K, Amano Y, Morizaki Y, Kadowaki T, Yamauchi T. Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19. Front Cardiovasc Med 2020;7:593061. [PMID: 33195481 DOI: 10.3389/fcvm.2020.593061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
324 Huizinga GP, Singer BH, Singer K. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection. Endocrinology 2020;161:bqaa154. [PMID: 32880654 DOI: 10.1210/endocr/bqaa154] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
325 Hasan SS, Kow CS, Bain A, Kavanagh S, Merchant HA, Hadi MA. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Expert Opin Pharmacother. 2021;22:229-240. [PMID: 33054481 DOI: 10.1080/14656566.2020.1837114] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
326 Sadhu AR, Serrano IA, Xu J, Nisar T, Lucier J, Pandya AR, Patham B. Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study. J Diabetes Sci Technol 2020;14:1065-73. [PMID: 33063556 DOI: 10.1177/1932296820964264] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
327 Li L, Spranger L, Soll D, Beer F, Brachs M, Spranger J, Mai K. Metabolic impact of weight loss induced reduction of adipose ACE-2 - Potential implication in COVID-19 infections? Metabolism 2020;113:154401. [PMID: 33065163 DOI: 10.1016/j.metabol.2020.154401] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
328 Al Hayek AA, Robert AA, Matar AB, Algarni A, Alkubedan H, Alharbi T, Al Amro A, Alrashidi SA, Al Dawish M. Risk factors for hospital admission among COVID-19 patients with diabetes. A study from Saudi Arabia. Saudi Med J 2020;41:1090-7. [PMID: 33026050 DOI: 10.15537/smj.2020.10.25419] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
329 Sachdeva S, Desai R, Gupta U, Prakash A, Jain A, Aggarwal A. Admission Hyperglycemia in Non-diabetics Predicts Mortality and Disease Severity in COVID-19: a Pooled Analysis and Meta-summary of Literature. SN Compr Clin Med 2020;:1-6. [PMID: 33073173 DOI: 10.1007/s42399-020-00575-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
330 Priyambada L, Wolfsdorf JI, Brink SJ, Fritsch M, Codner E, Donaghue KC, Craig ME. ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID-19 and resource-limited settings-role of subcutaneous insulin. Pediatr Diabetes 2020;21:1394-402. [PMID: 32935435 DOI: 10.1111/pedi.13118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
331 Shivane VK, Lila AR, Bandgar TR. Type 2 diabetic Asian Indians and COVID-19: Lessons learnt so far from the ongoing pandemic. J Postgrad Med 2020;66:179-81. [PMID: 33037170 DOI: 10.4103/jpgm.JPGM_602_20] [Reference Citation Analysis]
332 Shaw K. The significance of hyperglycaemia and other comorbidities during the COVID ‐19 pandemic. Pract Diab 2020;37:157-69. [DOI: 10.1002/pdi.2291] [Reference Citation Analysis]
333 Lockhart SM, Griffiths H, Petrisor B, Usman A, Calvo-latorre J, Heales L, Bansiya V, Mahroof R, Morris AC. The excess insulin requirement in severe COVID-19 compared to non-COVID-19 viral pneumonitis is related to the severity of respiratory failure and pre-existing diabetes.. [DOI: 10.1101/2020.10.03.20206284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
334 Holman N, Knighton P, Kar P, O'Keefe J, Curley M, Weaver A, Barron E, Bakhai C, Khunti K, Wareham NJ, Sattar N, Young B, Valabhji J. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol 2020;8:823-33. [PMID: 32798471 DOI: 10.1016/S2213-8587(20)30271-0] [Cited by in Crossref: 495] [Cited by in F6Publishing: 504] [Article Influence: 165.0] [Reference Citation Analysis]
335 Cherri S, Lemmers DHL, Noventa S, Abu Hilal M, Zaniboni A. Outcome of oncological patients admitted with COVID-19: experience of a hospital center in northern Italy. Ther Adv Med Oncol 2020;12:1758835920962370. [PMID: 33062065 DOI: 10.1177/1758835920962370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
336 Rao S, Ali K, Dennis J, Berdine G, Test V, Nugent K. Analysis of Glucose Levels in Patients Hospitalized With COVID-19 During the First Phase of This Pandemic in West Texas. J Prim Care Community Health 2020;11:2150132720958533. [PMID: 32924762 DOI: 10.1177/2150132720958533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
337 Kovil R, Shah T, Chawla M, Karkhanis S, Padhye D, Sanghvi A, Kale MC, Chawla P, Prabhu N, Dhandhania V, Shah K, Sachdev M, Methil V, Tanna S, Nayak K, Bagri S, Patil P, Gandhi A, Aversekar S, Maheshwari R, Kothari A, Dhope R, Mehta A; RACE Indian Author group. Patient reported changes in metabolic health during lockdown: A cross sectional digital connect survey in people with type 2 diabetes. Diabetes Metab Syndr 2020;14:1907-12. [PMID: 33011498 DOI: 10.1016/j.dsx.2020.09.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
338 Arredondo A. Comprehensive analysis of compliance with self-care guidelines and use of health services for patients with diabetes. J Diabetes 2021;13:173-4. [PMID: 32909648 DOI: 10.1111/1753-0407.13112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
339 Lazarus G, Audrey J, Wangsaputra VK, Tamara A, Tahapary DL. High admission blood glucose is an independent risk factor of poor prognosis in COVID-19: A systematic review and dose-response meta-analysis.. [DOI: 10.1101/2020.09.25.20200774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
340 McManus NM, Offman R, Oetman JD. Emergency Department Management of COVID-19: An Evidence-Based Approach. West J Emerg Med 2020;21:32-44. [PMID: 33052814 DOI: 10.5811/westjem.2020.8.48288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
341 Unnikrishnan R, Misra A. Infections and diabetes: Risks and mitigation with reference to India. Diabetes Metab Syndr 2020;14:1889-94. [PMID: 33002780 DOI: 10.1016/j.dsx.2020.09.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
342 Conway J, Gould A, Westley R, Raju SA, Oklopcic A, Broadbent A, Abdelhafiz AH, Sinclair AJ. Characteristics of patients with diabetes hospitalised for COVID-19 infection-a brief case series report. Diabetes Res Clin Pract 2020;169:108460. [PMID: 32971153 DOI: 10.1016/j.diabres.2020.108460] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
343 Lee MH, Wong C, Ng CH, Yuen DCW, Lim AYL, Khoo CM. Effects of hyperglycaemia on complications of COVID-19: A meta-analysis of observational studies. Diabetes Obes Metab 2021;23:287-9. [PMID: 32869450 DOI: 10.1111/dom.14184] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
344 Feldman EL, Savelieff MG, Hayek SS, Pennathur S, Kretzler M, Pop-Busui R. COVID-19 and Diabetes: A Collision and Collusion of Two Diseases. Diabetes. 2020;69:2549-2565. [PMID: 32938731 DOI: 10.2337/dbi20-0032] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 18.0] [Reference Citation Analysis]
345 Ogunleye OO, Basu D, Mueller D, Sneddon J, Seaton RA, Yinka-Ogunleye AF, Wamboga J, Miljković N, Mwita JC, Rwegerera GM, Massele A, Patrick O, Niba LL, Nsaikila M, Rashed WM, Hussein MA, Hegazy R, Amu AA, Boahen-Boaten BB, Matsebula Z, Gwebu P, Chirigo B, Mkhabela N, Dlamini T, Sithole S, Malaza S, Dlamini S, Afriyie D, Asare GA, Amponsah SK, Sefah I, Oluka M, Guantai AN, Opanga SA, Sarele TV, Mafisa RK, Chikowe I, Khuluza F, Kibuule D, Kalemeera F, Mubita M, Fadare J, Sibomana L, Ramokgopa GM, Whyte C, Maimela T, Hugo J, Meyer JC, Schellack N, Rampamba EM, Visser A, Alfadl A, Malik EM, Malande OO, Kalungia AC, Mwila C, Zaranyika T, Chaibva BV, Olaru ID, Masuka N, Wale J, Hwenda L, Kamoga R, Hill R, Barbui C, Bochenek T, Kurdi A, Campbell S, Martin AP, Phuong TNT, Thanh BN, Godman B. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future. Front Pharmacol 2020;11:1205. [PMID: 33071775 DOI: 10.3389/fphar.2020.01205] [Cited by in Crossref: 71] [Cited by in F6Publishing: 81] [Article Influence: 23.7] [Reference Citation Analysis]
346 Chowdhury TA, Waqar S, Hussain S, Ahmed SH, Syed A, Karamat A, Helmy A, Ghouri N. COVID-19, Diabetes and Ramadan. Diabetes Ther 2020;11:2447-51. [PMID: 32880875 DOI: 10.1007/s13300-020-00887-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
347 Mamtani M, Athavale AM, Abraham M, Vernik J, Amarah AR, Ruiz JP, Joshi AJ, Itteera M, Zhukovski SD, Madaiah RP, Hart P, Kulkarni H. ASSOCIATION OF HYPERGLYCEMIA WITH HOSPITAL MORTALITY IN COVID-19 PATIENTS WITHOUT DIABETES: A COHORT STUDY.. [DOI: 10.1101/2020.08.31.20185157] [Reference Citation Analysis]
348 Rajpal A, Rahimi L, Ismail-Beigi F. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. J Diabetes 2020;12:895-908. [PMID: 32671936 DOI: 10.1111/1753-0407.13085] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 19.7] [Reference Citation Analysis]
349 Kim SY, Kim KS. Letter: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (Diabetes Metab J 2020;44:405-13). Diabetes Metab J 2020;44:621-2. [PMID: 32856803 DOI: 10.4093/dmj.2020.0151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
350 Leong A, Cole J, Brenner LN, Meigs JB, Florez JC, Mercader JM. Cardiometabolic Risk Factors for COVID-19 Susceptibility and Severity: A Mendelian Randomization Analysis. medRxiv 2020:2020. [PMID: 32909013 DOI: 10.1101/2020.08.26.20182709] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
351 Pardo E. [Nutritional support for critically ill patients suffering from SARS-CoV-2 infection]. Prat Anesth Reanim 2020;24:218-24. [PMID: 32837212 DOI: 10.1016/j.pratan.2020.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
352 Kutlutürk F. COVID-19 Pandemisi ve Diabetes Mellitus. Turkish Journal of Diabetes and Obesity 2020;4:130-7. [DOI: 10.25048/tudod.746139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
353 Tabatabaei-Malazy O, Abdollahi M, Larijani B. Beneficial Effects of Anti-Oxidative Herbal Medicines in Diabetic Patients Infected with COVID-19: A Hypothesis. Diabetes Metab Syndr Obes 2020;13:3113-6. [PMID: 32943897 DOI: 10.2147/DMSO.S264824] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
354 Singh AK, Singh R. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Res Clin Pract. 2020;167:108382. [PMID: 32853686 DOI: 10.1016/j.diabres.2020.108382] [Cited by in Crossref: 95] [Cited by in F6Publishing: 100] [Article Influence: 31.7] [Reference Citation Analysis]
355 Santos LRD, Filho RB, Almeida Alves TAFD, Jardine MB, Duarte ML. Covid-19 and endocrinology – intersections: a review of current knowledge on physiopathological associations. EMIJ 2020;8:90-95. [DOI: 10.15406/emij.2020.08.00286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
356 Boyles GP, Thung S, Gabbe SG, Landon MB, Costantine MM. Practical considerations for pregnant women with diabetes and severe acute respiratory syndrome coronavirus 2 infection. Am J Obstet Gynecol MFM 2020;2:100210. [PMID: 32838276 DOI: 10.1016/j.ajogmf.2020.100210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
357 Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, Knighton P, Holman N, Khunti K, Sattar N, Wareham NJ, Young B, Valabhji J. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8:813-822. [PMID: 32798472 DOI: 10.1016/s2213-8587(20)30272-2] [Cited by in Crossref: 477] [Cited by in F6Publishing: 520] [Article Influence: 159.0] [Reference Citation Analysis]
358 Umpierrez G, Rushakoff R, Seley JJ, Zhang JY, Shang T, Han J, Spanakis EK, Alexanian S, Drincic A, Kulasa K, Mendez CE, Tanton D, Wallia A, Zilbermint M, Klonoff DC. Hospital Diabetes Meeting 2020. J Diabetes Sci Technol 2020;14:928-44. [PMID: 32783456 DOI: 10.1177/1932296820939626] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
359 Vikulova OK, Zuraeva Z, Nikankina LV, Shestakova MV. The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus. Diabetes mellitus 2020;23:242-249. [DOI: 10.14341/dm12501] [Reference Citation Analysis]
360 Kalmykova ZA, Kononenko IV, Sklyanik IA, Shestakova MV, Mokrysheva NG. Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19. Diabetes mellitus 2020;23:229-234. [DOI: 10.14341/dm12485] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
361 Wu L, Girgis CM, Cheung NW. COVID-19 and diabetes: Insulin requirements parallel illness severity in critically unwell patients. Clin Endocrinol (Oxf). 2020;93:390-393. [PMID: 32683745 DOI: 10.1111/cen.14288] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 15.0] [Reference Citation Analysis]
362 Weenink RP, Preckel B, Hulst AH, Hermanides J, de Jong MD, Schlack WS, Stevens MF, Sperna Weiland NH, Hollmann MW. Second Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management. J Clin Med 2020;9:E2542. [PMID: 32781614 DOI: 10.3390/jcm9082542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
363 Chee YJ, Tan SK, Yeoh E. Dissecting the interaction between COVID-19 and diabetes mellitus. J Diabetes Investig 2020;11:1104-14. [PMID: 32558211 DOI: 10.1111/jdi.13326] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
364 Hamdy O, Gabbay RA. Early Observation and Mitigation of Challenges in Diabetes Management of COVID-19 Patients in Critical Care Units. Diabetes Care 2020;43:e81-2. [PMID: 32444458 DOI: 10.2337/dc20-0944] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
365 Rahimi L, Malek M, Ismail-Beigi F, Khamseh ME. Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature. Adv Ther 2020;37:3450-62. [PMID: 32632851 DOI: 10.1007/s12325-020-01417-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
366 Gujral UP, Johnson L, Nielsen J, Vellanki P, Haw JS, Davis GM, Weber MB, Pasquel FJ. Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks. BMJ Open Diabetes Res Care 2020;8:e001520. [PMID: 32690631 DOI: 10.1136/bmjdrc-2020-001520] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
367 Goldstein DS. The extended autonomic system, dyshomeostasis, and COVID-19. Clin Auton Res 2020;30:299-315. [PMID: 32700055 DOI: 10.1007/s10286-020-00714-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 18.3] [Reference Citation Analysis]
368 Koliaki C, Tentolouris A, Eleftheriadou I, Melidonis A, Dimitriadis G, Tentolouris N. Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns. J Clin Med 2020;9:E2288. [PMID: 32708504 DOI: 10.3390/jcm9072288] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
369 Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8:782-792. [PMID: 32687793 DOI: 10.1016/s2213-8587(20)30238-2] [Cited by in Crossref: 478] [Cited by in F6Publishing: 518] [Article Influence: 159.3] [Reference Citation Analysis]
370 Bhatti R, Khamis AH, Khatib S, Shiraz S, Matfin G. Clinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID-19 Treatment in Dubai: Single-Centre Cross-Sectional Study (Preprint).. [DOI: 10.2196/preprints.22471] [Reference Citation Analysis]
371 Wang S, Ma P, Zhang S, Song S, Wang Z, Ma Y, Xu J, Wu F, Duan L, Yin Z, Luo H, Xiong N, Xu M, Zeng T, Jin Y. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia. 2020;63:2102-2111. [PMID: 32647915 DOI: 10.1007/s00125-020-05209-1] [Cited by in Crossref: 200] [Cited by in F6Publishing: 215] [Article Influence: 66.7] [Reference Citation Analysis]
372 Bhatti R, Amar H, Khattib S, Shiraz S, Matfin G. Clinical characteristics and outcomes in diabetes patients admitted with COVID-19 in Dubai: a cross-sectional single centre study.. [DOI: 10.1101/2020.07.08.20149096] [Reference Citation Analysis]
373 Sacks LJ, Pham CT, Fleming N, Neoh SL, Ekinci EI. Considerations for people with diabetes during the Coronavirus Disease (COVID-19) pandemic. Diabetes Res Clin Pract 2020;166:108296. [PMID: 32623041 DOI: 10.1016/j.diabres.2020.108296] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
374 Barone MTU, Harnik SB, de Luca PV, Lima BLS, Wieselberg RJP, Ngongo B, Pedrosa HC, Pimazoni-Netto A, Franco DR, Marinho de Souza MF, Malta DC, Giampaoli V. The impact of COVID-19 on people with diabetes in Brazil. Diabetes Res Clin Pract 2020;166:108304. [PMID: 32623040 DOI: 10.1016/j.diabres.2020.108304] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 11.3] [Reference Citation Analysis]
375 Papadokostaki E, Tentolouris N, Liberopoulos E. COVID-19 and diabetes: What does the clinician need to know? Prim Care Diabetes 2020;14:558-63. [PMID: 32654982 DOI: 10.1016/j.pcd.2020.06.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
376 Rafique S, Ahmed FW. A Case of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State in a Patient With COVID-19. Cureus 2020;12:e8965. [PMID: 32766007 DOI: 10.7759/cureus.8965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
377 Thaweerat W. Current evidence on pancreatic involvement in SARS-CoV-2 infection. Pancreatology 2020;20:1013-4. [PMID: 32498973 DOI: 10.1016/j.pan.2020.05.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
378 Li H, Tian S, Chen T, Cui Z, Shi N, Zhong X, Qiu K, Zhang J, Zeng T, Chen L, Zheng J. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes Metab. 2020;22:1897-1906. [PMID: 32469464 DOI: 10.1111/dom.14099] [Cited by in Crossref: 122] [Cited by in F6Publishing: 139] [Article Influence: 40.7] [Reference Citation Analysis]
379 Mazucanti CH, Egan JM. SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done? Immun Ageing 2020;17:21. [PMID: 32612666 DOI: 10.1186/s12979-020-00192-y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 12.0] [Reference Citation Analysis]
380 Bramante CT, Ingraham NE, Murray TA, Marmor S, Hovertsen S, Gronski J, McNeil C, Feng R, Guzman G, Abdelwahab N, King S, Meehan T, Pendleton KM, Benson B, Vojta D, Tignanelli CJ. Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19. medRxiv 2020:2020. [PMID: 32607520 DOI: 10.1101/2020.06.19.20135095] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 16.3] [Reference Citation Analysis]
381 Raoufi M, Khalili S, Mansouri M, Mahdavi A, Khalili N. Well-controlled vs poorly-controlled diabetes in patients with COVID-19: Are there any differences in outcomes and imaging findings? Diabetes Res Clin Pract 2020;166:108286. [PMID: 32592836 DOI: 10.1016/j.diabres.2020.108286] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
382 Anjana RM, Pradeepa R, Deepa M, Jebarani S, Venkatesan U, Parvathi SJ, Balasubramanyam M, Radha V, Poongothai S, Sudha V, Shanthi Rani CS, Ranjani H, Amutha A, Manickam N, Unnikrishnan R, Mohan V. Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown. Diabetes Technol Ther. 2020;22:527-534. [PMID: 32522031 DOI: 10.1089/dia.2020.0240] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
383 Evliyaoğlu O. Children with chronic disease and COVID-19. Turk Pediatri Ars 2020;55:93-4. [PMID: 32684753 DOI: 10.14744/TurkPediatriArs.2020.57805] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
384 Singh AK, Khunti K. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review. Diabetes Res Clin Pract 2020;165:108266. [PMID: 32533989 DOI: 10.1016/j.diabres.2020.108266] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 16.0] [Reference Citation Analysis]
385 Alkundi A, Mahmoud I, Musa A, Naveed S, Alshawwaf M. Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre study. Diabetes Res Clin Pract 2020;165:108263. [PMID: 32531325 DOI: 10.1016/j.diabres.2020.108263] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 13.0] [Reference Citation Analysis]
386 Klonoff DC. The Coronavirus 2019 Pandemic and Diabetes: An International Perspective. J Diabetes Sci Technol 2020;14:703-4. [PMID: 32517506 DOI: 10.1177/1932296820933075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
387 Schofield J, Leelarathna L, Thabit H. COVID-19: Impact of and on Diabetes. Diabetes Ther 2020;11:1429-35. [PMID: 32506222 DOI: 10.1007/s13300-020-00847-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
388 Boziki MK, Mentis AA, Shumilina M, Makshakov G, Evdoshenko E, Grigoriadis N. COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination. Brain Sci 2020;10:E345. [PMID: 32512702 DOI: 10.3390/brainsci10060345] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
389 Bellido V, Pérez A. Consequences of COVID-19 on people with diabetes. Endocrinología, Diabetes y Nutrición (English ed ) 2020;67:355-356. [DOI: 10.1016/j.endien.2020.04.008] [Reference Citation Analysis]
390 Mantovani A, Byrne CD, Zheng MH, Targher G. Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies. Nutr Metab Cardiovasc Dis. 2020;30:1236-1248. [PMID: 32571616 DOI: 10.1016/j.numecd.2020.05.014] [Cited by in Crossref: 150] [Cited by in F6Publishing: 157] [Article Influence: 50.0] [Reference Citation Analysis]
391 Singh AK, Singh R. Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19? Diabetes Metab Syndr 2020;14:725-7. [PMID: 32473903 DOI: 10.1016/j.dsx.2020.05.037] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
392 Dalan R. Is DPP4 inhibition a comrade or adversary in COVID-19 infection. Diabetes Res Clin Pract 2020;164:108216. [PMID: 32416120 DOI: 10.1016/j.diabres.2020.108216] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
393 Cole SA, Laviada-Molina HA, Serres-Perales JM, Rodriguez-Ayala E, Bastarrachea RA. The COVID-19 Pandemic during the Time of the Diabetes Pandemic: Likely Fraternal Twins? Pathogens 2020;9:E389. [PMID: 32438687 DOI: 10.3390/pathogens9050389] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
394 Lane EA, Barrett DJ, Casey M, Mcaloon CG, Collins ÁB, Hunt K, Byrne AW, Mcevoy D, Barber A, Griffin J, Wall P, More SJ. Country differences in hospitalisation, length of stay, admission to Intensive Care Units, and mortality due to SARS-CoV-2 infection at the end of the first wave in Europe: a rapid review of available literature.. [DOI: 10.1101/2020.05.12.20099473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
395 Bouhanick B, Cracowski JL, Faillie JL; French Society of Pharmacology, Therapeutics (SFPT). Diabetes and COVID-19. Therapie 2020;75:327-33. [PMID: 32425249 DOI: 10.1016/j.therap.2020.05.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
396 Mouhamad RS, Al-khafaji KA, Allami RH, Alabboud M, Hameed Abdulla M, Jafaar MM. The epidemiological plateau of Corona virus in Gulf countries: a descriptive statistics study. RB 2020;5:1142-1149. [DOI: 10.21931/rb/2020.05.02.12] [Reference Citation Analysis]
397 Bellido V, Pérez A. Consequences of COVID-19 on people with diabetes. Endocrinol Diabetes Nutr (Engl Ed) 2020;67:355-6. [PMID: 32475769 DOI: 10.1016/j.endinu.2020.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
398 Hillson R. COVID ‐19: diabetes and death. A call to action. Pract Diab 2020;37:76-8. [DOI: 10.1002/pdi.2271] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
399 Ceriello A. Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory. Diabetes Res Clin Pract 2020;163:108186. [PMID: 32360400 DOI: 10.1016/j.diabres.2020.108186] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 16.0] [Reference Citation Analysis]
400 Mohamed F, Raal FJ, Mbelle M, Zamparini J, Venturas J, Shaddock E, Diana N, Mer M, Dingezweni S, Bolon S, Smith O, Mahomed A, Kalla I, University of the Witwatersrand, Johannesburg. Glycaemic Characteristics and Outcomes of COVID-19 Patients Admitted to a Tertiary Hospital in Johannesburg. WJCM 2020;2:123. [DOI: 10.18772/26180197.2020.v2n3a1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
401 Barone MTU, Ngongo B, Menna-Barreto L. Sleep-wake cycle impairment adding on the risk for COVID-19 severity in people with diabetes. Sleep Sci 2020;13:191-4. [PMID: 33381286 DOI: 10.5935/1984-0063.20200038] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
402 [DOI: 10.1101/2020.09.12.20193235] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
403 [DOI: 10.1101/2020.10.19.20214395] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Reference Citation Analysis]